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This monograph presents a historical perspective of cornerstone developments on the
biochemistry and physiology of mammalian membrane guanylate cyclases (MGCs),
highlighting contributions made by the authors and their collaborators. Upon resolution
of early contentious studies, cyclic GMP emerged alongside cyclic AMP, as an important
intracellular second messenger for hormonal signaling. However, the two signaling
pathways differ in significant ways. In the cyclic AMP pathway, hormone binding to a
G protein coupled receptor leads to stimulation or inhibition of an adenylate cyclase,
whereas the cyclic GMP pathway dispenses with intermediaries; hormone binds to
an MGC to affect its activity. Although the cyclic GMP pathway is direct, it is by no
means simple. The modular design of the molecule incorporates regulation by ATP
binding and phosphorylation. MGCs can form complexes with Ca2+-sensing subunits
that either increase or decrease cyclic GMP synthesis, depending on subunit identity.
In some systems, co-expression of two Ca2+ sensors, GCAP1 and S100B with ROS-
GC1 confers bimodal signaling marked by increases in cyclic GMP synthesis when
intracellular Ca2+ concentration rises or falls. Some MGCs monitor or are modulated
by carbon dioxide via its conversion to bicarbonate. One MGC even functions as a
thermosensor as well as a chemosensor; activity reaches a maximum with a mild drop
in temperature. The complexity afforded by these multiple limbs of operation enables
MGC networks to perform transductions traditionally reserved for G protein coupled
receptors and Transient Receptor Potential (TRP) ion channels and to serve a diverse
array of functions, including control over cardiac vasculature, smooth muscle relaxation,
blood pressure regulation, cellular growth, sensory transductions, neural plasticity and
memory.
Keywords: membrane guanylate cyclase, cyclic GMP, signal transduction, ANF-RGC, ROS-GC, ONE-GC, neuronal
calcium sensor, bicarbonate
INTRODUCTION
Initially relegated to the shadows of cyclic AMP signaling, cyclic GMP has slowly ascended to
eminence as an important independent signal in the body, governed by the activities of soluble
and membrane guanylate cyclases (MGCs) and phosphodiesterases. Here, we briefly outline the
chronological development of the field of mammalian MGCs, focusing on how the modular design
of the receptor enzyme adds layers of complexity to its biochemistry and physiological function.
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Variations in the modules confer flexibility and enable MGCs
to command a pervasive signaling role over diverse functions
throughout the body. Some of the advancements made by
the authors and their collaborators are featured. For more
comprehensive coverage, the reader is referred to the authors’
earlier reviews: (Sharma (1978, 1985, 2002, 2010); Pugh et al.
(1997); Sharma et al. (2004, 2014); Duda et al. (2005b, 2014);
Sharma and Duda (2012, 2014a,b)).
Cyclic GMP Is a Hormonal Second
Messenger
An observation made five decades ago, that cyclic GMP exists
in rat urine (Ashman et al., 1963) and the finding that its
level in urine depends upon hormonal state (Hardman and
Sutherland, 1969; Hardman et al., 1969) were early clues
that cyclic GMP serves as a hormonal second messenger.
Guided by a prototypic cyclic AMP template, this concept
implicated a membrane receptor guanylate cyclase transduction
system in vertebrates. In the beginning, there was passionate
enthusiasm for this concept and in support, cyclic GMP was
present and guanylate cyclase catalytic activity was detected
in all tested tissues (Goldberg et al., 1969, 1973; Ishikawa
et al., 1969). But with reports that guanylate cyclase catalytic
activity was stimulated by a variety of non-hormonal ligands:
polyunsaturated fatty acids, peroxides, hydroperoxides, free
radicals, ascorbic acid, sodium nitroprusside, and cigarette
smoke (Goldberg and Haddox, 1977; Murad et al., 1979), a
notion took hold in which MGC was a non-specific enzyme
regulated by the cell’s oxidation-reduction potential. In extreme
views, no component of cyclic GMP turnover was regarded as
linked directly to an intracellular signaling pathway. Where it
was found, cyclic GMP turnover was believed to be subordinate
to the cyclic AMP signaling system. As a case in point, the
known cyclic GMP-dependent protein kinase activity showed
some cross-reactivity with cyclic AMP and was thus interpreted
as a means for augmenting cyclic AMP signaling (Gill and
McCune, 1979).
A few groups pushed on, not willing to relinquish a primary
role for cyclic GMP as a second messenger role in hormonal
signal transduction (reviewed in Sharma, 1978, 1985; Sharma
et al., 1988a,b; Pugh et al., 1997; Sharma and Duda, 1997,
2012, 2014a,b; Sharma, 2002, 2010; Duda et al., 2005b, 2014;
Sharma et al., 2015). Two key observations proved to be
instrumental in resolving the matter. First, an ACTH-sensitive
MGC transduction system exists in rat adrenocortical carcinoma
494 cells and in isolated adrenal fasciculata cells (Perchellet and
Sharma, 1980; Shanker and Sharma, 1980; Jaiswal and Sharma,
1986; Jaiswal et al., 1986; Venkataraman et al., 1998; reviewed
in Sharma, 2010). Second, unlike adrenal homogenates, isolated
adrenal fasciculate and adrenocortical carcinoma cells lack cyclic
AMP phosphodiesterase activity. These systems were therefore
ideal for testing whether cyclic AMP is the sole hormonal second
messenger or whether ACTH evokes MGC activity (Kitabchi
et al., 1971; Sharma, 1972).
Physiological levels of ACTH (1–10 µU) stimulate
steroidogenesis, yet do not raise the level of cyclic AMP (Figure 1;
FIGURE 1 | Dose-response relations for the levels of cyclic GMP, cyclic
AMP and corticosterone as a function of ACTH in suspensions of
isolated adrenal cells of rat. Cyclic GMP (black circles) and corticosterone
(black squares) are produced at [ACTH] too low to affect cyclic AMP
synthesis. At higher [ACTH], activation of a phosphodiesterase counteracts
GMP synthesis and cyclic AMP levels (gray circles) rise to further increase
steroidogenesis. Modified, with permission, from Sharma et al. (1974). One
micro unit (µU) of ACTH is equal to 4.5 pg or 1.2 × 10−13 moles.
Sharma et al., 1974). Moreover, there exists an excellent temporal
relation between cyclic GMP formation (Sharma et al., 1974;
Harrington et al., 1978), phosphorylation and steroidogenesis
(Sharma, 1973; Sharma et al., 1976; Perchellet et al., 1978)
at these hormone concentrations. Exogenous cyclic GMP
mimics ACTH in stimulating protein kinase activity, followed
by conversion of cholesterol to corticosterone (Sharma et al.,
1976; Sharma and Sawhney, 1978). Eventually, direct evidence
was obtained for the presence of ACTH/Ca2+-dependent
MGC activity in adrenocortical and adrenocortical carcinoma
plasma membranes (Nambi and Sharma, 1981a,b; Nambi
et al., 1982a,b). At levels an order of magnitude higher, ACTH
will elevate cyclic AMP and drive steroidogenesis further
but these levels extend into the supra-physiological range
(Sharma et al., 1974, 1976). Thus, cyclic GMP is the principal
physiological second messenger of ACTH in isolated adrenal
fasciculate and adrenocortical carcinoma cells and cyclic AMP
is not the sole second messenger for hormonal signaling in
the body.
Two challenges were mounted against these ideas. First, a
dibutyryl cyclic AMP analog was the most effective activator of
cyclic AMP-dependent protein kinase, yet dibutyryl cyclic GMP
evoked far less steroidogenic activity than its parent compound
cyclic GMP (Hayashi et al., 1979). Second, incubation of
adrenocortical cells with sodium nitroprusside and ascorbic
acid incremented cyclic GMP levels without stimulating
the production of corticosterone (Laychock and Hardman,
1978). Both challenges were overcome upon purification
and characterization of the cyclic GMP-dependent protein
kinase from the adrenal cortex (Ahrens et al., 1982). In
a playful twist of NATURE, the cyclic GMP-dependent
protein kinase differs from the cyclic AMP-dependent
protein kinase in several curious ways. The most potent
effector molecule for cyclic GMP-dependent protein kinase is
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8-bromo cyclic GMP; dibutyryl cyclic GMP is almost totally
ineffective (Ahrens et al., 1982). Perhaps more surprisingly,
it turns out that nitroprusside and ascorbate inhibit cyclic
GMP-dependent protein kinase activity (Sharma et al.,
1988a,b).
After a heme-dependent soluble guanylate cyclase was
purified from bovine lung (Ignarro et al., 1982a,b), it became
clear that only the soluble guanylate cyclase is stimulated by
free radical-, nitric oxide (NO)-generating agents, including
heme; such agents produce little or no effect on MGC (Nambi
et al., 1982b; Sharma et al., 1989b). It was thus established that
guanylate cyclases exist in membrane and soluble forms each
with distinct biochemical properties, and that their signaling
roles do not necessarily overlap. In rat adrenal cortex, most
(80%) of the guanylate cyclase is membrane-bound and only a
minor amount (20%) is soluble (Nambi et al., 1982b; Sharma
et al., 1989b). In the second challenge above, it was this
minor fraction that was stimulated by sodium nitroprusside and
ascorbic acid.
In its current status, the soluble form of the guanylate cyclase
is encoded by two genes [the functionalities of β2 cloned from rat
kidney and α2, from human fetal brain, remain to be determined
(Denninger andMarletta, 1999)]. It is heterodimeric and requires
heme for its activity (Figure 2; Allerston et al., 2013; Sharma
and Duda, 2014a). As will be described below, MGCs are quite
different. In mammals, MGCs are encoded by seven different
genes and although dimerization is requisite for activity, it would
appear that only homodimers are formed in situ.
Atrial Natriuretic Factor Receptor
Guanylate Cyclase (ANF-RGC) Was the
First Membrane Guanylate Cyclase to be
Purified and Characterized
Purification and characterization of an MGC from rat
adrenocortical carcinoma (Paul, 1986; Paul et al., 1987; Sharma,
1988; Sharma and Duda, 2014b) and subsequently from adrenal
cortex (Takayanagi et al., 1987; Meloche et al., 1988) brought the
discovery that it is a receptor for atrial natriuretic factor (ANF).
This receptor MGC, named ANF-RGC, provides the basis
for ANF-stimulated cyclic GMP and corticosterone synthesis
(Jaiswal et al., 1986). Presumably a similar MGC responds
to ACTH, but confirmation is not yet available. The original
report noted, ‘‘coexistence of the ANF receptor and guanylate
cyclase activities on a single polypeptide chain indicates that the
mechanism of transmembrane signal transduction involving
mediation by second messenger, cyclic GMP, is different from
the well-established adenylate cyclase system. In hormone-
dependent adenylate cyclase there is an assemblage of individual
components—receptor, GTP binding protein, and catalytic
moiety—for signal transduction. In contrast, the presence of
dual activities—receptor binding and enzymatic—on a single
polypeptide chain indicates that this transmembrane protein
contains both the information for signal recognition and
its translation into a second messenger’’ (Paul et al., 1987).
Accordingly, a multimodal ANF-RGC signal transduction
model was envisioned (Sharma et al., 1988a,b, 1989a) and
refined (Sharma, 2002; Figure 2). Its central features were that a
hormone receptor domain protruded into the extracellular space,
a catalytic domain resided inside the cell and a transmembrane
segment linked the two.
The same antibody used to purify ANF-RGC to homogeneity
from adrenocortical carcinoma and from adrenal cortex
indicated a much wider expression including testes (Marala and
Sharma, 1988), neurons located in the ventral horn region of rat
spinal cord, cerebellar Purkinje cells, and renal glomerular cells
(Ballermann et al., 1988). The milestone discovery of ANF-RGC
would revolutionize the basic cellular signal transduction field as
well as the field of clinical cardiovascular physiology.
An intriguing finding of the early studies was the obligatory
presence of Ca2+ for hormonal stimulation of steroidogenesis
(Sayers et al., 1972; Haksar and Péron, 1973; Bowyer and
Kitabchi, 1974), yet by itself, Ca2+ was ineffective. Only
when present with the hormone, did it become an effective
steroidogenic factor (Perchellet and Sharma, 1979). Although the
underlying mechanism could have been indirect and has still not
been clarified, Ca2+ would be found to play a profound role in
regulating MGC activity and diversifying its functionality as the
field of MGCs progressed.
MGCs Are Constructed with a Modular
Design
About 3-years post-purification, the mRNA of ANF-RGC was
cloned (Chinkers et al., 1989; Lowe et al., 1989; Pandey and
Singh, 1990; Duda et al., 1991). Cloning and sequencing of
two more family members soon followed (Chang et al., 1989;
Schulz et al., 1989; Duda et al., 1993c). Like ANF-RGC (or
GC-A), the new guanylate cyclases are receptors for hormones:
type C-natriuretic peptide for one receptor and guanylin,
uroguanylin and heat stable enterotoxin for the other, hence,
they were named CNP-RGC (or GC-B) and STa-RGC (or GC-C),
respectively.
Hydropathy analysis suggests that all three receptors are
modular, with nearly identical topographies. The extracellular
portion forms the hormone-binding domain and embodies the
maximal structural diversity. The intracellular portion starts with
a kinase-like domain that stretches up to a catalytic domain,
(Duda et al., 1991). By applying recombinant tools to MGCs
and guided by the theoretical ANF-RGC structural template
it was possible to test the multi-modularity concept, map the
domains and define their functional components and predict
the transmembrane migration of the hormonal signal at a
sub-molecular level.
The first task was to establish that the extracellular domain
(ExtD) of ANF-RGC truly does constitute the hormone’s
(ANF) signaling site. A genetic variant of ANF-RGC (GCα),
cloned from the adrenal cortex, has a structure that varies
in just two amino acid residues from the ExtD of the true
ANF-RGC: His338 substitutes for Gln and Pro364 substitutes
for Leu (Duda et al., 1991). GCα supports normal basal
catalytic activity, yet it is not an ANF receptor. Transformation
of its residues 338 and 364 to the true ANF-RGC residues
confers ANF-binding and regulatory activities indicating
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FIGURE 2 | Comparison of soluble and membrane guanylate cyclases (MGCs). The soluble form is a heterodimer of α and β subunits with a single heme
capable of binding nitric oxide (NO). The C-terminal segments of both subunits contribute to the catalytic center. The MGC is a single transmembrane spanning
protein that is active as a homodimer. Heme binding does not occur. A transmembrane domain (TM) divides the protein into two roughly equal parts, an extracellular
domain (ExtD) and an intracellular domain (ICD). Within the ICD, corresponding C-terminal segments from each monomer, arranged in an antiparallel orientation, form
the catalytic center. Both types of cyclases are lyases (EC4.6.1.2) that catalyze synthesis of cyclic GMP from GTP. Note that the relative sizes of the modules are not
drawn to scale. Redrawn, with permission, from Sharma and Duda (2014a).
the necessity for Gln338 and/or Leu364. Subsequent point
mutation analyses single out Leu364 as the key residue for
controlling both activities. Historically, GCα was the first
naturally occurring ANF-RGCmutation functionally linked with
hormonally-dependent core catalytic domain (CCD) activity
(Duda et al., 1991).
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The amino acid residues in CNP-RGC corresponding to
Gln338 and Leu364 in ANF-RGC are Glu332 and Val358,
respectively. For CNP-RGC, Glu332 in the ExtD is critical for
C-type natriuretic peptide (CNP) binding and CNP-dependent
catalytic regulatory activity (Duda et al., 1993c, 1994). As with
Leu364 in ANF-RGC, the site has no influence on the basal
catalytic activity of the guanylate cyclase. The folding patterns
of the external domains of these two guanylate cyclases are
nearly identical (Duda et al., 1994). Substitution of the Gln338
residue with Glu endows ANF-RGC with significant CNP signal
transduction activity (Duda et al., 1995). Conversely, replacing
Val358 with Leu generates significant ANF signal transduction
activity in CNP-RGC. These two residues therefore perform
equivalent functions in controlling the ligand specificities of
ANF-RGC and CNP-RGC. Subsequent X-ray crystallographic
analyses provided validation and revealed the ExtDs to exist as
homo-dimers in a head to head conformation (He et al., 2001;
Ogawa et al., 2004, 2009).
Hormonal Signal Transduction Is
ATP-Regulated
An enigmatic observation was that despite binding ANF
stoichiometrically, the catalytic activity of purified ANF-RGC
was not stimulated (Paul et al., 1987). Two groups solved
this puzzle (Chinkers et al., 1991; Marala et al., 1991); ATP
is obligatory for ANF-dependent ANF-RGC activity. Neither
ANF nor ATP alone is sufficient. Since two nonhydrolyzable
analogs, ATPγS and AMP-PNP, mimic ATP with EC50s between
0.3–0.5 mM (Duda et al., 1993a), phosphorylation need not
occur and ATP must be an allosteric regulator (Chinkers et al.,
1991; Marala et al., 1991). With Hill coefficients near 1 (Duda
et al., 2011b), it is not clear whether one ATP per dimer is
adequate or whether two ATPs drive greater activity than one.
Importantly, the identical situation exists for CNP transduction
by recombinant CNP-RGC (Duda et al., 1993c).
Definition of the mechanism by which ATP controls
transmission of the hormonal signal at the sub-molecular
level was achieved through two decades of programmed
study (reviewed in Sharma, 2010). A vaguely termed, ‘‘kinase
homology domain (KHD)’’ of ANF-RGC extends from a
juxtamembrane domain (JMD) to the CCD (Chinkers and
Garbers, 1989; Marala et al., 1992). Within the KHD, a
glycine rich cluster (GRC), Gly503-Arg-Gly-Ser-Asn-Tyr-Gly509
bestows ATP-dependence to ANF transduction (Goraczniak
et al., 1992). Hence, this motif was more aptly renamed
ATP-regulatory module (ARM). The ARM in CNP-RGC is
Leu497-Arg-Gly499-Ser-Ser-Tyr-Gly503. If the ANF-RGC-ARM
sequence is changed to its CNP-RGC counterpart, the ATP
dependence of the ANF response is preserved (Duda et al.,
1993a). Together with the earlier finding that the entire KHDs
of ANF-RGC and CNP-RGC are interchangeable (Koller et al.,
1992), the transduction mechanisms of these two MGCs appear
to function identically. Evaluation of individual glycine residues
in the ARM sequence homed in on Gly505 in ANF-RGC
and the identically placed Gly499 in CNP-RGC as critical
for ATP binding and ANF signal transduction (Duda et al.,
1993b).
The ANF-RGC ARM domain was simulated through
homology-based modeling, patterning it after the x-ray crystal
structures of insulin receptor kinase and hematopoietic cell
kinase. In turn, its functional elements were experimentally
decoded through point mutation/expression, time-resolved
tryptophan fluorescence and Forster Resonance Energy
Transfer, reconstitution and mass spectroscopic studies
(Figure 3A). The greater ARM boundaries stretch from
residues 481–771. A smaller, 91 residue N-terminal lobe
(496–586) connects to a larger, 185 residue C-terminal
lobe (587–771; Duda et al., 2000; Sharma et al., 2001;
Figure 3B). ATP binding partially amplifies the ANF
signal by repositioning a W669-TAPELL675 motif in the
larger lobe. This repositioning is critical for hormone-
dependent activation of ANF-RGC; deletion of the WTAPELL
motif results in an ANF-RGC that is unresponsive to
ANF and ATP in the recombinant system (Duda et al.,
2009) and in a genetically modified mouse model, causes
hypertension and cardiac hypertrophy (Duda et al., 2013).
Thus, the seven-residue encoded motif of ANF-RGC
gene exerts total control over the hormonal regulation of
blood pressure.
Binding of ATP also causes buried serine and threonine
residues in GRC-P within the smaller lobe of the ARM to
shift to the surface, whereupon they are phosphorylated by
a hypothetical kinase. Full amplification of the ANF signal is
achieved by phosphorylation. Maximal activity is self-limiting,
however, because ANF-RGC loses affinity for ANF upon ATP
binding (Larose et al., 1991; Jewett et al., 1993; Duda and Sharma,
1995a,b) and loses affinity for ATP after phosphorylation.
Based on additional observations that dephosphorylation of
ANF-RGC underlies homologous desensitization (Potter and
Garbers, 1992), we propose a working model for activation
(Figure 3C). ATP and ANF can bind ANF-RGC independently,
but in the absence of ATP, ANF cannot stimulate cyclic GMP
synthesis. ATP binding exposes six serines and threonines in the
ARM, enabling them to be phosphorylated. Dephosphorylation
can occur but the residues can then be re-phosphorylated.
The conformational changes also lower the affinity for ANF
binding. Phosphorylation promotes ATP release, which helps
return of the receptor to the basal state by reducing activity
and slowing the rate of phosphorylation. Dephosphorylation
continues as long as ANF is bound. When ANF dissociates,
the serines and threonines in ARM fold back into the
receptor and lose access to phosphatase and kinase. If
dephosphorylation is complete, then the receptor can bind
ANF, but is completely inactive until it also binds ATP and
is re-phosphorylated. But with residual phosphorylation, ANF
binding alone elicits weak activity. Full activation requires
ATP binding and phosphorylation of all residues. A central
theme of the model is that it is dynamic. Notably, this
operational mode selectively controls the regulatory activity
of ANF without affecting the basal catalytic activity of ANF-
RGC. It appears that the same model applies to the ligand-
dependent activation of CNP-RGC and STa-RGC (Potter
and Hunter, 1998; Bhandari et al., 2001; Jaleel et al.,
2006).
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FIGURE 3 | Model for signal transduction by atrial natriuretic factor-receptor guanylate cyclase (ANF-RGC). (A) Important module segments involved in
activation. An ANF-signaling element (ANF-SE) resides in the ExtD. A Central Switch (CS), L364, controls the ANF binding site. A Binding Pocket (BP) is hinged with
the CS (van den Akker et al., 2000; Ogawa et al., 2004, 2009). Two disulfide bridged cysteine residues act as a Transduction Node (TN) to guide the transmembrane
migration of the ANF signal to an intracellular, ATP-Regulated Module (ARM; Duda et al., 2005b). ATP amplifies the ANF signal by bringing two critical domains to the
surface: a glycine rich cluster (GRC), G-X-G505-X-X-X-G, making surrounding serine and threonine available for phosphorylation (GRC-P) and a 7-aa residue
W669-TAPELL675 motif to activate the core catalytic domain (CCD). (B) Structure of the ARM in its apo form. Four antiparallel β strands and one helix constitute the
small lobe. The large lobe is made up of eight α helices and two β strands. The positions of the key G505 residue of the GRC motif within the small lobe and of the
W669-TAPELL675 motif within the large lobe are indicated. ATP binding is sandwiched between the two lobes (indicated by a star; modified, with permission, from
Duda et al., 2000; Sharma et al., 2001). (C) Activation model for ANF-RGC. Binding of an ANF molecule to the ExtDs of the dimer primes the ANF-SE, by rotating
TN. The twisting motion propagates through TM to prepare ARM for ATP binding (Ogawa et al., 2004; Parat et al., 2010). ATP binding triggers a cascade of temporal
and spatial changes (Duda et al., 2001c). With G505 in GRC-P acting as a pivot, the ATP BP shifts its position and its floor rotates. There is movement of ARM’s β4
and β5 strands and the loop between them and movement of the αE and F helices that exposes the hydrophobic WTAPELL motif for interaction with CCD (Duda
et al., 2009). These structural rearrangements initiate 50% maximal catalytic activity. Full activation is attained after multiple serines and threonines in GRC-P become
phosphorylated (Duda et al., 2011b). The conformational changes wrought by ATP binding reduce the affinity of ANF-RGC for ANF and phosphorylation lowers the
affinity for ATP binding. Dissociation of ANF and ATP return ANF-RGC to its ground state. Modified with permission, from Duda et al. (2011b).
MGCs Transduce Intracellular Ca2+ Signals
Phototransduction, the conversion of light into an electrical
signal in the outer segments of rod and cone photoreceptors,
marks the first step in the visual process. By the 1980s, it was
known that both Ca2+ and cyclic GMP were critical cytosolic
regulators of the photon response. Eventually, cyclic GMP was
proven to be the second messenger of phototransduction when it
was shown to increase directly the conductance of a new class
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of ion channels for which phosphorylation was not necessary
(Fesenko et al., 1985). This discovery brought a major paradigm
shift because until that time, cyclic nucleotides were thought to
act exclusively through a kinase intermediary. However, critical
issues remained: What was the source of the cyclic GMP? How
did Ca2+ fit in? (reviewed in Pugh and Cobbs, 1986; Stryer,
1986).
To find answers, a search for the molecular identity of the
photoreceptor ROS-GC was undertaken. After initial failures
(Horio and Murad, 1991a,b; Shyjan et al., 1992), in a cutting
edge finding, a protein was successfully purified from bovine
rod outer segments (ROS) and its sequence was pieced together
from protein fragments. Subsequent sequence-based molecular
cloning established the true molecular structure of ROS-GC1
(Margulis et al., 1993; Goraczniak et al., 1994). Based on the
bovine ROS-GC1 structure, the molecular structure of the
original ret-GC (Shyjan et al., 1992) was corrected in 1995 to
show that it is the human version of the bovine form (Lowe DG,
accession number M92432). Notably, ROS-GC1 is the lone MGC
to have its molecular identity established on the basis of protein
sequence. Comparison of the results to those obtained by cloning
led to the realization that ROS-GC is preceded by an N-terminal
leader sequence (LS) that gets deleted post-translationally. The
theoretical molecular mass of the protein with the 56-amino acid
LS is 120, 361 Da; without it, it is 114, 360 Da (Goraczniak
et al., 1994). The 114, 360 Da molecular mass was similar to the
previously biochemically characterized bovine (Koch, 1991) and
toad photoreceptor guanylate cyclases (Hayashi and Yamazaki,
1991). Unlike ANF-RGC and CNP-RGC (Paul et al., 1987; Chang
et al., 1989; Chinkers et al., 1989; Duda et al., 1993c), ROS-GC1
is not modulated by natriuretic peptide hormone (Goraczniak
et al., 1994). For that matter, no extracellular ligands have
ever been identified, so ROS-GC1 remains an orphan surface
receptor. A second ROS-GC (ROS-GC2) was discovered in
bovine retina (Goraczniak et al., 1997), the human version was
termed Ret-GC2 (Lowe et al., 1995). Recombinant ROS-GC1
and ROS-GC2 organize into homodimers and heterodimers,
but few if any heterodimers form in bovine retina despite the
co-expression of both guanylate cyclases in rods (Yang and
Garbers, 1997).
In a groundbreaking discovery, a soluble bovine ROS fraction
stimulated the catalytic activity of photoreceptor guanylate
cyclase in the absence of Ca2+ (Koch and Stryer, 1988).
Three separate groups purified two similar but molecularly
distinct guanylate cyclase activating proteins (GCAPs): GCAP1
(Palczewski et al., 1994; Subbaraya et al., 1994; Gorczyca et al.,
1995; Frins et al., 1996) and GCAP2 (Dizhoor et al., 1995).
For ROS-GC1 expressed in a heterologous system of COS
cells catalytic activity increases 4–5 fold with the addition of
GCAP1 at 10 nM Ca2+. Activity then falls approximately 6-
fold as Ca2+ is raised to 1 µM with an IC50 near 100 nM
(Duda et al., 1996b; Figure 4A). The small discrepancy between
these magnitudes of activity change comes about because
GCAP becomes an inhibitor at high Ca2+ (Dizhoor and
Hurley, 1996). ROS-GC1 in membranes of the photoreceptor
outer segments membranes treated with exogenous GCAP1
or GCAP2 behaves similarly (Figure 4A). These results along
with cross-linking experiments (Duda et al., 1996b) affirm
the association of GCAP1 with ROS-GC1 at low and high
Ca2+ levels, making GCAP1 a Ca2+-sensing subunit of the
cyclase.
Recombinant GCAP2 provides more powerful stimulation
of recombinant ROS-GC1 at low Ca2+, but the EC50 of
ROS-GC1 for GCAP2 of 6–8 µM is nearly an order of
magnitude higher than the EC50 of ∼0.8 µM for GCAP1
(Duda et al., 1996b; Goraczniak et al., 1998; Krishnan et al.,
1998). ROS-GC2 is stimulated by GCAP2 at low Ca2+ by
12-fold with an EC50 of 1 µM. However, GCAP1 is not
capable of stimulating ROS-GC2 or ANF-RGC at low Ca2+
(Duda et al., 1996b; Goraczniak et al., 1998). The binding
sites on ROS-GC1 for the two Ca2+ sensing subunits were
mapped by peptide competition and mutagenesis experiments
(Figure 4C). Two short sequences, M445-L456 and L503-I522,
in the JMD of ROS-GC1 are critical and specific for GCAP1
activation (Lange et al., 1999). The regulatory site for GCAP2,
Y965-N981, is located in a C-terminal extension (CTE) of
the CCD (Duda et al., 2005a). Despite their having binding
sites positioned on opposite sides of the CCD, both GCAPs
utilize the W657-TAPELL663 motif in ARM to amplify their
stimulation of catalytic activity at low Ca2+ (Duda et al.,
2011a). ATP binding is not obligatory, but will raise basal
catalytic activity and GCAP1-stimulated activity at low Ca2+
by the same increment (Gorczyca et al., 1994; Aparicio and
Applebury, 1996). Remarkably, ROS-GC exhibits intrinsic kinase
activity and autophosphorylates four serine residues in its
ARM (Aparicio and Applebury, 1996; Bereta et al., 2010). At
present, the purpose of ROS-GC1 phosphorylation is a complete
mystery; it produces no change in basal or GCAP1-stimulated
activities and its occurrence is unrelated to Ca2+ regulation by
GCAP1.
Rods and cones are not responsive to light in ROS-GC1/ROS-
GC2 double knockout mice (Baehr et al., 2007) and guanylate
cyclase activity loses its Ca2+ dependence in GCAP1/GCAP2
double knockout mice (Mendez et al., 2001). Expression of
a third guanylate cyclase and a third GCAP linked with
phototransduction is thereby excluded in mouse. In human
retina there is a third GCAP capable of stimulating ROS-GC1
and ROS-GC2. It has Ca2+ regulatory properties similar to
those of GCAP1 so its role in phototransduction is unclear
(Haeseleer et al., 1999). Apparently mammalian photoreceptors
utilize a Ca2+-modulated system composed of a pair of ROS-
GCs and up to three GCAPs in their outer segments. Studies
on mice deficient for either GCAP1 or GCAP2 (Makino et al.,
2008, 2012) verify a relay model for how the two GCAPs
operate in the rod (Koch and Dell’Orco, 2013). GCAP1 has
the lower affinity for Ca2+ so it is the first responder to
the light-induced fall in intracellular Ca2+. Over time after
light onset and with higher intensities, the effect of GCAP1
saturates and stimulation of ROS-GC activity by GCAP2
becomes increasingly important. Together, the two GCAPs
limit the growth of the photon response and accelerate the
kinetics of the response recovery (Figure 4B). More complete
accounts of the molecular properties of ROS-GCs and how
ROS-GC systems control phototransduction may be found
Frontiers in Molecular Neuroscience | www.frontiersin.org 7 September 2016 | Volume 9 | Article 83
Sharma et al. Membrane Guanylate Cyclase Networks
FIGURE 4 | Ca2+- sensing subunits of rod outer segment-guanylate cyclase (ROS-GC). (A) Ca2+-dependence of ROS-GC1 activity in washed bovine ROS
membranes. In the presence of recombinant guanylate cyclase activating protein (GCAP), activity is stimulated when Ca2+ is low and suppressed when Ca2+ is high.
The “IC50” for Ca2+ was 707 ± 122 nM for GCAP1 and 100 ± 32 nM for GCAP2. The dose response curves were cooperative with Hill coefficients of 1.5 and 2.4 for
GCAP1 and GCAP2, respectively. Results from Hwang et al. (2003). The difference in IC50 values for Ca2+ between GCAP1 and GCAP2, observed for the first time
in this study, inspired the proposal of the “Ca2+ relay” model for the GCAP1 and GCAP2 modulation of ROS-GC activity (Koch and Dell’Orco, 2013). (B) Effects of
GCAPs on the photon responses of rods from WT, GCAP1−/−, GCAP2−/− and GCAPs double knockout (GCAPs−/−) mice. In the absence of both GCAPs, the single
photon response rises for a longer period to an amplitude ∼5 fold larger than normal and recovers very slowly. Knockout of GCAP1 alone results in a compensatory
overexpression of GCAP2. The rising phase of the photon response is not quite as prolonged as with GCAPs−/− but the amplitude is still ∼2 fold larger than normal.
GCAP1 levels appear to be normal after knockout of GCAP2. The photon response is normal in amplitude but takes somewhat longer to recover (Results from Wen
et al., 2014). (C) Modular construction of the ROS-GC1 dimer. A 56 amino acid leader sequence (LS) precedes the ExtD in the nascent, immature protein. All
signaling events occur in ICD, which is composed of: JMD, juxtamembrane domain; KHD, kinase homology domain; SHD, signaling helix domain; CCD, catalytic
core domain; and CTE, C-terminal extension. Two specific switches for Ca2+ sensing subunits, one for GCAP1 in the JMD, and one for GCAP2 in the CTE, are
located on opposing sides of the CCD. The MGC complex exists as a dimer of homodimers in which two ROS-GC1s combine either two GCAP1s or two GCAP2s.
in Sharma and Duda (2014a); Wen et al. (2014); Koch and
Dell’Orco (2015).
The discovery that intracellular Ca2+ regulates cyclic GMP
synthesis in photoreceptormembranes shattered the concept that
MGCs limit themselves to the transduction of hormones and
other extracellular signals. Moreover it foreshadowed a greater
complexity in signaling in other MGC transduction systems.
CD-GCAP Supports Bimodal Ca2+
Switching of ROS-GC Activity
Discovered contemporaneously with GCAPs, retinal CD-GCAP
presented itself as another Ca2+-dependent regulator of ROS-GC
(reviewed in Sharma et al., 2014). CD-GCAP turned out to be
a conformational isomer of brain S100B (the only commercially
available form; Pozdnyakov et al., 1995, 1997; Duda et al., 1996a,
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2002; Margulis et al., 1996; Wen et al., 2012). But in contrast
to the Zn2+-bound brain form, the retinal form has Ca2+-
bound. The distinction is significant because the Zn2+-bound
form inhibits while the Ca2+-bound form stimulates ROS-GC1
(Pozdnyakov et al., 1997). The rest of the review will concern
itself only with the retinal form.
S100B can be chemically cross-linked to the ROS-GC1
dimer giving evidence for a direct interaction. In recombinant
systems, S100B binds ROS-GC1 with a K1/2 of 198–395 nM
(Duda et al., 2002) and stimulates cyclic GMP synthesis with
a K1/2 for Ca2+ of ∼400 nM (Duda et al., 1996a). Deletion
constructs of ROS-GC1 and peptide competition studies
map the interaction to C-terminal segments: aa962–981 and
aa1030–1042. Within these segments, an R966-IHVNS972 motif
is obligatory for binding while a flanking cluster, R1039–RQK1042,
that does not contribute to S100B binding, promotes maximal
ROS-GC1 activation (Duda et al., 2002). As a diminutive protein
with an estimated molecular weight of 10 kDa and only 2 EF
hands, it organizes into a tetrameric subunit of theMGC complex
(Donaldson et al., 1995).
With the ability to couple to GCAPs and to S100B, ROS-GC1
could function as a bimodal Ca2+ switch in cells expressing
all three components. The hypothesis was explored at the
photoreceptor-bipolar synaptic region of the bovine retina where
prior immunohistochemical studies had demonstrated the co-
presence of ROS-GC1 with GCAP1 and S100B (Liu et al., 1994;
Cooper et al., 1995; Duda et al., 2002). Indeed, ROS-GC1 activity
is high in synaptosomal membranes from retina at 10 nM Ca2+,
decreases as Ca2+ is raised to a few hundred nM and then
rises again as Ca2+ exceeds 1 µM (Venkataraman et al., 2003;
Figure 5).
The presence of ROS-GC1, GCAPs and S100B in the outer
segments of the retinal photoreceptors (Cuenca et al., 1998; Kachi
et al., 1999; Rambotti et al., 1999) implicated a role for bimodal
switching in phototransduction. The possibility was probed with
mouse knockout models: S100B−/−, GCAP1−/−, GCAP2−/−,
GCAP1/GCAP2−/−, ROS-GC1−/−. Biochemical experiments on
FIGURE 5 | Bimodal Ca2+ switching in photoreceptor to bipolar cell
synaptosomal membranes of WT mice. Stimulation of catalytic activity at
high Ca2+ is missing from membranes of S100B−/− mice and from those of
ROS-GC1−/− mice. Error bars show SEM. Modified with permission from Wen
et al. (2012); copy right S. Karger AG., Basel.
murine outer segments demonstrate functional linkage of S100B
with ROS-GC1 but not ROS-GC2 at [Ca2+]i > 200 nM in the
generation of cyclic GMP. Although these concentrations exceed
the physiological range for Ca2+ in mouse ROS (Woodruff et al.,
2002), they may be appropriate for cones, which sustain higher
levels of Ca2+ in darkness. It therefore makes sense that the most
recent immunocytochemistry co-localizes S100B and GCAP1
with ROS-GC1 in murine retinal cone outer segments but not
ROS (Wen et al., 2012).
Bicarbonate Controls a Ca2+-Independent
Mode in ROS-GC that is Interlaced with
Ca2+-Sensing Modulators
In trailblazing studies, the MGC in olfactory neuroepithelium
[olfactory neuroepithelial guanylate cyclase (ONE-GC), see
below] was shown to be a sensor of atmospheric carbon dioxide
(Hu et al., 2007; Guo et al., 2009). The mediator of the carbon
dioxide signaling was bicarbonate. Bicarbonate did not stimulate
recombinant ANF-RGC, CNP-RGC, STa-RGC, or ROS-GCs
in these first studies, leading to the conclusion that among
MGCs, bicarbonate was an activator unique to ONE-GC (Guo
et al., 2009; Sun et al., 2009). Truncation mutants point to
an interaction of bicarbonate directly with the broadly defined
CCD to spur the generation of cyclic GMP (Sun et al., 2009;
Duda and Sharma, 2010). The exclusive responsivity of ONE-GC
to bicarbonate seemed odd because there is 85% structural
conservation of its catalytic domain across MGCs. Revisiting the
issue showed that the catalytic activities of recombinant bovine
ROS-GCs are stimulated robustly by bicarbonate, ROS-GC1 with
an ED50 of 27 mM and a Hill coefficient of 2.8, and ROS-
GC2 with an ED50 of 39 mM and a Hill coefficient of 2.3
(Duda et al., 2015). The Hill coefficients >2 are consistent with
one or more bicarbonate molecules binding to each monomer.
Bicarbonate has a similar effect on ROS-GCs in photoreceptor
outer segment membrane preparations (Figure 6A). ROS-GC’s
catalytic activity remains constant over a range of pH from 7
to 9, ruling out a pH dependent mechanism for bicarbonate
stimulation. The conflicting results from the first two studies
may be related to the type of expression system because
although bicarbonate lowers the activity of ANF-RGC expressed
in CHO, the effect is not so marked with the same MGC
expressed in E. coli or in HEK-293 (Guo et al., 2009; Sun et al.,
2009).
The bicarbonate signal transduction of ROS-GC1 occurs
independently of [Ca2+]i. Yet, it synergizes with the Ca2+-
sensors: GCAP1, GCAP2 and S100B to intensify Ca2+
modulation, particularly for GCAP2 (Duda et al., 2015,
2016). The effect on photoreceptors is to elevate the circulating
current, decrease sensitivity to flashes and accelerate flash
response recovery. As a charged molecule, bicarbonate does
not freely cross membranes and gains access to ROS-GC
in ROS by entering through the inner segment/synapse of
intact rods. In contrast, bicarbonate can access ROS-GC
from the inner and outer segments of red-sensitive cones.
The basis is under active investigation. These findings
clarify a large body of seemingly controversial studies
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FIGURE 6 | Bicarbonate modulation of ROS-GC activity. (A) Stimulation
of ROS-GC in photoreceptor outer segment preparations from WT and neural
retina leucine zipper transcription factor knockout (NRL−/−) mice. NRL−/−
photoreceptors express ROS-GC1 and GCAP1 exclusively. The dependence
of guanylate cyclase activity on bicarbonate is cooperative with an EC50 of
47 mM. The elevated activity at high bicarbonate concentration in WT outer
segments is attributed to their additional expression of GCAP2. Error bars
show SEM (Duda et al., 2015). (B) Ca2+-dependent and -independent
modulators of ROS-GC 1 activity. Upper panel: three Ca2+ sensor
proteins—GCAP1, GCAP2 and S100B— and one Ca2+-independent
modulator, bicarbonate, target individually the indicated domains within the
intracellular portion of ROS-GC1. Lower panel: the targeted domains are
specific switches all of which signal activation of the catalytic domain. The
signaling pathways are indicated as dashed arrows.
surrounding bicarbonate and cyclic GMP synthesis in
retinal photoreceptors and provided a clue that bicarbonate
signaling would be characteristic of most, if not all MGCs.
A model showing the interlaced Ca2+-dependent and -
independent pathways in the photoreceptors is depicted in
Figure 6B.
An F514S mutation in ROS-GC1 causes Leber’s congenital
amaurosis type 1 blindness in human patients (Perrault
et al., 1996, 1999; Rozet et al., 2001). There is a 10-fold
loss in ROS-GC1 catalytic activity (Duda et al., 1999) that
is almost totally insensitive to GCAP1 modulation, despite
retention of GCAP1 binding to ROS-GC (Duda et al., 2016).
It follows that the loss in GCAP1 modulation occurs at
the signal transduction level and possibly resides in one or
more of the catalytic core residues: D834, E874, D878, R925,
C946, N953. In contrast, the mutation does not abolish Ca2+-
modulation by GCAP2 or by S100B (Duda et al., 1999,
2016), even though the absolute activities are reduced in all
conditions. The interaction of this disease-causing mutation with
bicarbonate led to some insights into the intramolecular signaling
pathways.
Bicarbonate partially raises basal catalytic as well as GCAP2-
and S100B-stimulated activities of the F514S mutant but does
little for the deficit in GCAP1 stimulation. The restorative
capacity of bicarbonate indicates that it operates downstream
or independently of the F514S mutation. At the basic level these
findings support the earlier conclusion that the S100B- and
GCAP2-modulated pathways within ROS-GC1 overlap (Duda
et al., 2002) but that both are distinct from the GCAP1-
modulated pathway (Duda et al., 1996a, 2012c; Krishnan et al.,
1998; Koch et al., 2010; Koch and Dell’Orco, 2013).
At a clinical level, high enough bicarbonate levels could
provide relief for patients expressing the F514S-mutant ROS-GC
by restoring some basal and GCAP2-modulated guanylate
cyclase activity in rods and cones. Mice stricken with the
mutation would not be so fortunate, since their cones express
GCAP1 to the exclusion of GCAP2 (Xu et al., 2013).
Another Ca2+ Sensor, Neurocalcin δ (NCδ)
Is Expressed in Retinal Neurons
The failure of GCAP1 to recognize the KHD of ANF-
GC and satisfy its Ca2+ requirement (Duda et al., 1996a)
meant that other Ca2+-sensing subunits participate in MGC
signaling. The neuronal calcium sensor (NCS) neurocalcin δ
(NCδ) was tested as a potential ROS-GC regulator because
it shares ∼35% sequence identity with GCAPs and is
expressed in the inner retina. Ca2+-free bovine brain NCδ
has no effect on recombinant ROS-GC1, but the Ca2+-
bound form stimulates it with a K1/2 for Ca2+ of 0.8 µM
(Krishnan et al., 2004). Stimulation is ROS-GC1-specific;
it does not occur with ROS-GC2. In these respects NCδ is
functionally more similar to S100B than to GCAPs. NCδ
bears four EF hands while S100B has only two. Despite
the poor sequence identity of S100B to the C-terminal half
of NCδ (GenBank accession numbers NP_001029727.1
and NP_776823.1, respectively), a comparison of their
Ca2+-bound crystal structures reveals that the four helix-packing
arrangements of their EF hands are very similar (Kumar et al.,
1999). Thus, NCδ and S100B are structural and functional
analogs.
NCδ purified from bovine retina exists as a homodimer
of 20 kDa proteins (Krishnan et al., 2004; Venkataraman
et al., 2008). Like other NCSs (Ladant, 1995; Frins et al.,
1996), NCδ exhibits a Ca2+-dependent mobility shift. Of
the four EF-hand motifs, only three—EF2, EF3, EF4—are
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predicted to bind Ca2+ (Okazaki et al., 1992; Terasawa et al.,
1992; Vijay-Kumar and Kumar, 1999). The N-terminus
is blocked, predominantly by myristoylation, a feature
in common with all other members of the NCS-protein
family except the Kv-channel interacting protein subfamily
(Braunewell and Gundelfinger, 1999; Burgoyne and Weiss,
2001). Many members, NCδ included, operate as a Ca2+
myristoyl switch wherein the myristoyl group lies buried
within a hydrophobic pocket in the absence of Ca2+, but
is exposed when Ca2+ is bound to increase the membrane
affinity of the protein (Lim et al., 2014). Without Ca2+,
NCδ has no affinity for ROS-GC1. Yet from a functional
standpoint, NCδ behaves as a true subunit of ROS-GC1,
because the resting intracellular Ca2+ concentration of
100–200 nM is sufficient to keep NCδ membrane bound
and associated with ROS-GC1. Stability enables a response of
the MGC complex on a millisecond time scale. This concept
has been experimentally validated. NCδ and ROS-GC1 are
present together in the IPL under resting conditions and
the addition of Ca2+ stimulates native ROS-GC1 activity
(Krishnan et al., 2004); the myristoyl group of NCδ causes a
2-fold amplification of the saturation activity of ROS-GC1.
The binding kinetic parameters of the Ca2+-bound NCδ with
ROS-GC1 are (Krishnan et al., 2004): KA = 2.3 × 106 M−1 and
KD = 4.6× 10−7 M.
Mapping studies place binding of NCδ at aa732–962, a
site that does not overlap with GCAP1-, GCAP2-, or S100B-
modulated domains of ROS-GC1 (Krishnan et al., 2004). Finer
analyses pinpoint the NCδ-modulated site between V836-L857
of ROS-GC1 (Note: the sequence numbering in the following
reference is offset by one amino acid; Venkataraman et al.,
2008), within the CCD. This segment is accessible to the solvent
and fits comfortably in the V-shaped crevice of NCδ, bounded
by the EF-1 hand residues. These residues form a special
hydrophobic–hydrophilic patch, which may be a distinctive
feature of the Ca2+-dependent signaling property of NCδ. It has
a secondary structure of helix-loop-helix and is acidic in nature
with a pI of 3.37.
Traditionally, the belief had been that the CCD, located
at the C-terminus of the protein, was isolated from all of
its ligands and depend on upstream modules to translate
the ligand signals for its activation to generate cyclic GMP.
The localization of NCδ binding, which predated work on
the bicarbonate binding site, along with new insights on the
antiparallel nature of the catalytic center (Duda et al., 2012c),
called for a new signaling model in which the isolated core
catalytic module by itself is dimeric in nature with intrinsic
basal guanylate cyclase activity. The two chains of the catalytic
module are antiparallel. Ca2+-bound NCδ interacts directly with
the ROS-GC1 core catalytic site without need for the adjacent
N-terminally located α-helical ‘‘dimerization domain’’ structural
element (L770-P807). Because this dimerization domain plays a
role in transmitting the signal from GCAP1 to the catalytic
module (Zägel et al., 2013), it is now referred to as signaling helix
domain (SHD).
ROS-GC1 couples with another NCS in the inner retina, most
likely a GCAP, because cyclic GMP synthesis increases at very
low Ca2+ (Krishnan et al., 2004). If the entire system is present
in the same cells, then it could function as bimodal switch like
that at the photoreceptor-bipolar cell synapse, except that NCδ
replaces S100B.
NCδ Is a Ca2+ Sensor Modulating ANF-RGC
Based on the rationale that the binding site for NCδ lies in the
catalytic center of ROS-GC, a domain that is conserved in all
MGCs, NCδ was a prime candidate to be the Ca2+ sensor for
ANF-RGC. The V836-L857 site in ROS-GC1 corresponds with the
V851-L872 site of ANF-RGC with a sequence identity of 68.2%.
The first step was to test myristoylated NCδ against
recombinant ANF-RGC. NCδ stimulates the catalytic activity
of ANF-RGC in a dose-dependent fashion with an EC50 of
0.5 µM Ca2+ (Duda et al., 2012b). As is the case with ROS-GC1
and GCAPs, ATP/ANF is not needed for stimulation, further
demonstrating that the Ca2+-modulated modes are distinct from
that of hormonal, ANF signal transduction. These properties
broke down the traditional concept that ANF-RGC was strictly
a transducer of the natriuretic peptide hormone ANF. A second,
Ca2+-modulated pathway regulates the same physiological
processes of natriuresis, diuresis and blood pressure.
Only myristoylated NCδ stimulates the Ca2+-modulated
ANF-RGC catalytic activity, the non-myristoylated form is
ineffectual. It is now appreciated that in a previous study,
Ca2+/NCδ did not stimulate ANF-GC (Kumar et al., 1999)
because it was unmyristoylated, underscoring the importance of
this posttranslational modification. Myristoylated NCδ controls
the activity of ANF-RGC by lowering its Km for GTP substrate
and by increasing its catalytic efficiency, kcat, from 6.5 ± 0.3
to 41.4 ± 0.5 pmol cyclic GMP/s. The functional unit of the
Ca2+-bound complex is composed of NCδ dimer and ANF-RGC
dimer.
To assess an overlap between the Ca2+- and the ANF-
modulated pathways, ANF-RGC catalytic activity was analyzed
first in the presence of 1 µM Ca2+ and 2 µMmyristoylated NCδ
and then with increasing concentrations of ANF, ranging from
10−11 to 10−6 M, and constant 0.8 mM ATP. The responses
were enhanced 3.5- and 4.5-fold alone, and about 15-fold in
combination. Thus the Ca2+-modulated and the hormone-
modulated pathways can operate independently but when both
are in play, the multiplicative power suggests a convergence in
their control of ANF-RGC transduction activity.
To link cardiovascular biochemistry with physiology, a
hemizygous NCδ knockout mouse, NCδ+/−, was generated
(Duda et al., 2012b). We were unsuccessful in generating
viable homozygous NCδ knockout mice. The adrenocortical
zona glomerulusa was chosen as the subject of investigation
because the ANF-RGC signal transduction system is present in
glomerulosa cells (Takayanagi et al., 1987; Sharma et al., 1989b;
Duda et al., 1991; Rondeau et al., 1995), and NCδ is expressed
in the same layer (Nakano et al., 1993). The particulate fraction
of the adrenal gland from NCδ+/− mice yields 50% of the
normal ANF-RGC activity and addition of saturating amounts
of exogenous NCδ and Ca2+ reconstitutes the full MGCs activity.
Thus, the Ca2+-dependent NCδ-modulated ANF-RGC signaling
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pathway exists in the adrenal glands of the mice and, as
anticipated, it is only functionally half as active in NCδ+/− mice
compared to wild type mice.
ANF-RGC catalytic activity in the adrenal gland offsets the
renin-angiotensin aldosterone system; it inhibits aldosterone
synthesis and thereby lowers blood pressure (Burnett et al.,
1984; Aoki et al., 2000; Shi et al., 2001). Aldosterone
levels in the plasma of NCδ+/− mice are 27% higher over
the control NCδ+/+ mice (Duda et al., 2014). Together
with the evidence that corticosterone levels synthesized by
fasciculata cells are unaffected by the absence of NCδ gene
and immunohistochemical studies showing that NCδ and
ANF-RGC are co-expressed in the glomerulosa cells of themouse
adrenal gland, the conclusion is that the Ca2+-modulated ANF-
RGC transduction machinery resides specifically in aldosterone
producing glomerulosa cells of the adrenal gland (Duda et al.,
2012b). Importantly, it is physiologically linked with blood
pressure regulation. Systolic blood pressure of the NCδ+/− mice
is 38% higher than in wild type mice, 127 vs. 92 mm Hg.
In conclusion, ANF-RGC performs two transductions in
some systems. One signal arrives externally in the form of
potent hormones, ANF and brain natriuretic peptide (BNP),
which bind to an external surface domain. The second
signal is internal; a neurocalcin subunit monitors intracellular
Ca2+ and directly modulates the catalytic domain (Figure 7).
This Ca2+-modulation defines a new paradigm of ANF-RGC
signaling and unveils an alternate pathway to the physiological
control of the endocrine systems that avert hypertension.
The NCS VILIP-1 can bind to ANF-RGC (Braunewell et al.,
2001). If VILIP-1 modulates activity of ANF-RGC as it
does for CNP-RGC, it may substitute for NCδ in other
systems.
An MGC (ONE-GC, GC-D) Detects
Odorants
Cloning of a MGC, termed GC-D, from a total olfactory cDNA
library (Fulle et al., 1995) came at a time when olfaction was
thought to occur solely through G protein coupled receptors and
the cyclic AMP signaling pathway (Buck, 1995; Belluscio et al.,
1998; Breer, 2003; Lai et al., 2005). Even though an odorant
for GC-D was not yet known, there were clues for a cyclic
GMP transduction system in olfaction. In situ hybridization and
immunocytochemical studies indicate that GC-D co-expresses
with a cyclic GMP stimulated phosphodiesterase, PDE2, that
hydrolyzes cyclic GMP as well as cyclic AMP and an ion channel
that is gated specifically by cyclic GMP (Fulle et al., 1995; Juilfs
et al., 1997; Meyer et al., 2000). GC-D/PDE2 containing neurons
constitute only a small subpopulation of neuroepithelial neurons
for which components of the ‘‘standard’’ olfactory cyclic AMP
signaling system: Golf , ACIII, PDE1C2, and the α3 and β1b
subunits of the cyclic nucleotide gated ion channel, are missing.
Moreover, they project to specific ‘‘necklace glomeruli’’ of the
olfactory bulb. Interestingly, immunoprobes with different anti-
GC-D antibodies uncover more extensive labeling of olfactory
neuroepithelial cilia suggesting the possible expression of more
than one type of MGC and/or a subsidiary role for cGMP in a
FIGURE 7 | Independence of the signaling pathways of ANF/ATP and of
NCδ. The trajectory of the ANF pathway (maroon dashed arrow) originates at
the ExtD and passes through the TM, ARM and signaling helix domain (SHD)
in its course to CCD. In contrast, the trajectory of the NCδ pathway (blue
dashed arrow) lies within the CCD. The ANF-RGC dimer is thought to bind a
dimer of NCδ, but only a single subunit is shown. Both pathways are the
physiological regulators of the mouse blood pressure.
majority of the olfactory receptors (Juilfs et al., 1997; Duda et al.,
2001a).
A Ca2+-modulated ROS-GC1 system is absent from rat
olfactory neuroepithelium and its ciliary subcompartment where
odorants are transduced, so to assess the possibility that a novel
MGC is involved, the authors cloned ONE-GC directly from
a rat olfactory neuroepithelium cDNA library (Duda et al.,
2001a). Sequence alignment analysis disclosed that ONE-GC has
complete primary structural identity with the prior cloned GC-D
(Juilfs et al., 1997), yet only partial 47.9% and 47.6% identity with
ROS-GC1 and ROS-GC2, respectively. A polyclonal antibody
raised against its unique 12 amino acid C-terminal epitope
revealed that it shares no immunological identity with ROS-GC1
nor with ROS-GC2 (Duda et al., 2001a). Thus, ONE-GC and
GC-D are the same guanylate cyclase. Because ONE-GC resides
in the olfactory neuroepithelium compartment, the authors
prefer the ONE-GC nomenclature over GC-D.
The Ca2+-modulated myr-NCδ-ONE-GC system meets five
criteria set forth to secure its role as a genuine, Ca2+-modulated
odorant transducer (Duda et al., 2001a, 2004; Duda and Sharma,
2008; Sharma and Duda, 2010): (1) ONE-GC responds to
odorant in its native state. Uroguanylin is an extremely effective
stimulus for ONE-GC expressing neurons (Leinders-Zufall et al.,
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2007), binding the ExtD of ONE-GC with an EC50 of 20 pM and
saturating it at 500 pM (Duda and Sharma, 2008). Interestingly,
STa-RGC binds uroguanylin and guanylin, but ONE-GC is more
selective and does not recognize guanylin; (2) The response to
odorant is relatively fast for an amplifying system; (3) ONE-GC
resides within the membrane portion of the cilia; (4) It is
modulated by physiological concentrations of free Ca2+ with a
K1/2 of 700 nM, generating responses similar to that of odorant;
and (5) The Ca2+-responsive system can be reconstituted with
recombinant myr-NCδ and ONE-GC.
NCδ binds M880-L921 of ONE-GC, a segment encompassing
the corresponding V836-L857 binding site in ROS-GC1 (see
above), affording direct access to the catalytic domain (Duda
and Sharma, 2008). The key 844MSEPIE849 motif in ROS-GC1
is present in ONE-GC as 908LSEPIE913. In vivo cell studies
demonstrate that in resting cells, the NCδ-ONE-GC complex is
exclusively at the plasma membrane region (Duda et al., 2004).
Assessed by the SPR spectroscopy, kinetic parameters of the
Ca2+-bound NCδ binding to ONE-GC are: KD = 2.8 × 10−7 M;
kon = 5.7× 103 M−1s−1; koff = 1.56× 10−3 s−1.
Gene-knockout studies in mouse establish that in olfactory
neuroepithelium another NCS, hippocalcin (Hpca; Krishnan
et al., 2009) activates ONE-GC catalytic activity in the Ca2+ K1/2
range of 0.5–0.7 µM. Besides neurocalcin and Hpca, ONE-GC
interacts with yet one more Ca2+ sensor, GCAP1 (Pertzev
et al., 2010). The interaction was missed initially, because it is
antithetical to that with ROS-GC in phototransduction. Instead
of stimulating ONE-GC at the low nM range of free Ca2+ (i.e.,
in the Ca2+ free state), GCAP1 stimulates at the upper range
of Ca2+ (i.e., in the Ca2+ bound state; Duda et al., 2006, 2012a;
Figure 8). It was the first, and is to date, the only example of an
NCS switching the directionality of its action with a change in
binding partners. To add to the intrigue, stimulation of ONE-GC
activity by GCAP1 occurs at an EC50 that is higher than the
apparent IC50 for ROS-GC1 activity. Biochemical assays with
antibodies indicate that 35% of the total ONE-GC transduction
activity is controlled by GCAP1, 27% by NCδ, and 38% by Hpca
(Krishnan et al., 2009; reviewed in Sharma and Duda, 2010).
ONE-GC resembles the ANF-RGC in combining a surface
hormone/odorant transduction with internal Ca2+ sensing. Yet,
a primary sequence identity of only 28.1% with ANF-RGC but
a sequence identity of 47.6% with ROS-GC makes it closer akin
to the latter subfamily. Like photoreceptor ROS-GCs, ONE-GC
is stimulated by bicarbonate (Guo et al., 2009; Sun et al., 2009).
The target site of the bicarbonate signal resides within Y922-P1028
segment of the catalytic domain (Hu et al., 2007; Sun et al., 2009;
Duda and Sharma, 2010).
Additional Ca2+ Sensors Couple to MGC in
Hippocampus
The Ca2+ sensor frequenin (Frq, also termed NCS type-1,
NCS-1) is themost primordial member of theNCS protein family
with homologs already present in yeast (Fik-Rymarkiewicz et al.,
2006; reviewed in Sharma and Duda, 2012). While frequenin
supports Ca2+ modulation with numerous targets, its status with
respect to MGCs was unknown. It was of interest to test MGCs
because the results could provide clues about the timeline for the
evolutionary appearance of NCS-MGC interactions. Bovine Frq
has a subunit mass of 22 kDa and shows a Ca2+-dependent gel
mobility shift, a characteristic of the NCS family (Ladant, 1995).
Its structure is highly conserved on the evolutionary ladder: 100%
identity with chicken (Nef et al., 1995; Olafsson et al., 1997;
McFerran et al., 1999) rat, and human (Jeromin et al., 1999;
Bourne et al., 2001); 98% with frog (Olafsson et al., 1995), 75%
with C. elegans (De Castro et al., 1995), 72% with Drosophila
(Pongs et al., 1993), and 60% with the yeast form (Hendricks
et al., 1999). In common with the NCS family trait, there are four
EF-hands, yet only three—2, 3 and 4—are functional in binding
Ca2+. Frq is myristoylated but its operation as a Ca2+ myristoyl
switch is somewhat controversial (Lim et al., 2011).
Co-immunoprecipitation experiments demonstrate that Frq
and a ONE-GC-like MGC exist as a complex in bovine
hippocampal neurons (Fik-Rymarkiewicz et al., 2006). When
these studies were conducted, no Ca2+-modulated MGC
transduction machinery had ever been reported in hippocampus.
The existence of the complex is Ca2+-dependent, dissociating
when the Ca2+ is depleted with EGTA. Interestingly, a small
fraction of Frq immunoprecipitates with the hippocampal MGC
even in the presence of 5 mM EGTA. The MGC and the native
NCS from hippocampal neurons respond to [Ca2+] with a five-
fold increase in activity and a K1/2 for Ca2+ of 0.7 µM. The
EC50 of hippocampal MGC for recombinant myr-Frq is 0.7 µM,
and at saturating levels of Ca2+, activity increases five-fold.
Recombinant myr-Frq robustly stimulates the catalytic activity
FIGURE 8 | Antithetical Ca2+ modulation of ROS-GC1 and olfactory
neuroepithelial guanylate cyclase (ONE-GC) activities by GCAP1. In the
presence of GCAP1, the catalytic activity of recombinant ROS-GC1 decreases
as Ca2+ is raised from 1 nM to 100 µM, but the catalytic activity of
recombinant ONE-GC increases. Western blots confirming ROS-GC1 and
ONE-GC expression are shown above. Redrawn from Duda et al. (2012a).
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of recombinant ONE-GC 6-fold with an EC50 of 0.7 µM, only
marginally (∼1.5-fold) stimulates recombinant ROS-GC1, and
utterly fails to stimulate ROS-GC2. The binding kinetics between
Frq and the M836-C1110 segment of ONE-GC were determined
through surface plasmon resonance spectroscopy: KD =0.43 µM;
kon (the association rate constant) = 7.14 × 103M−1s−1;
koff (dissociation rate constant) = 3.04 × 10−3s−1; and KA
(equilibrium association constant) = 2.35 × 106 M−1. Frq
therefore may be a soluble modulator rather than a true subunit
of the hippocampal MGC. Functionally, a mixed distribution
of Frq bound to a minor fraction of the hippocampal MGC
and free Frq in the cytoplasm of resting neurons could serve to
effectively raise the Ca2+ requirement, extend the Ca2+ range
and lengthen the duration of the rise in Ca2+ necessary for
stimulation of cyclic GMP synthesis. Modulation of an MGC
by myr-Frq suggests that during evolution, Ca2+-sensors that
stimulate MGCs at high Ca2+ probably arose before the GCAPs
that stimulate at low Ca2+.
These results argue in favor of a ONE-GC-like MGC in
hippocampus, but its identity remains elusive because GC-D is
not expressed in bovine. Hippocalcin, which can couple with
ONE-GC (vide supra, Krishnan et al., 2009), is potentially a
second soluble Ca2+ modulator of MGCs in hippocampus.
CNP-RGC is another hippocampal MGC, responding to
CNP produced locally (Langub et al., 1995; Herman et al.,
1996). Mutant rats with a defective response to CNP show
disturbances in long term potentiation and long term depression
(Barmashenko et al., 2014). These studies on hippocampus begin
to unravel a role for MGCs in learning and memory.
A Novel MGC (GC-G) Responds to Mild
Cooling
A seventh MGC, GC-G, was cloned from rat with some
suggestion for alternative splicing (Schulz et al., 1998). The
realization that GC-G is expressed in selected, temperature-
sensitive neurons of the Grueneberg Ganglion in the nasal cavity
of mouse (Fleischer et al., 2009) led to the remarkable discovery
that GC-G is a thermosensor (Chao et al., 2015), reminiscent
of MGCs encoded by gcy-8, gcy-18 and gcy-23 in C. elegans
(Takeishi et al., 2016). The molecular mechanism has not yet
been defined but it would appear that dimerization of the CCD
is optimal near 15◦C with a sharp temperature dependence
(Figure 9). GC-G is multifunctional—it also responds to the
predator odorant 2,4,5-trimethylthiazoline (Chao et al., 2015)
and to bicarbonate (Chao et al., 2010). Modulation by Ca2+ is
not yet known. Activation of Grueneberg Ganglion neurons by
mild cooling elicits ultrasound vocalization in pups, a behavior
that is attenuated in GC-G knockouts (Chao et al., 2015).
New Functions of Ca2+-Interlocked MGCs
Continue to Be Uncovered
GC-D has degraded to a pseudogene in most primates (Young
et al., 2007), and GC-G appears to have lost its capacity to
function as a cyclase in humans (Yang et al., 2010), nevertheless,
there is growing appreciation for the extensive roles that the other
FIGURE 9 | Thermosensing by GC-G. (A) Temperature dependence of
GC-G activity. Membranes of HEK293T cells transfected with GC-G cDNA or
empty vector were used to determine the guanylate cyclase activity at the
indicated temperatures for 20 min. (B) Uniqueness of GC-G in its stimulation
by cool temperature. Expression plasmids encoding FLAG-tagged versions of
all known MGCs were transfected into HEK-293T cells and their membranes
were used for guanylate cyclase activity assays at 37 and 15◦C. ANF-RGC,
CNP-RGC, and STa-RGC showed little change, whereas ROS-GC1,
ROS-GC2 and ONE-GC showed greater activity at 37◦C. Error bars show SD.
∗p < 0.05, ∗∗p < 0.01. Analysis by Western blot with anti-FLAG antibodies
confirms the expression of each MGC. Reproduced with permission from
Chao et al. (2015): Receptor guanylyl cyclase-G is a novel thermosensory
protein activated by cool temperatures. EMBO J 34:294-306, © John Wiley
and Sons, Inc.
MGCs have taken on throughout the body (Kuhn, 2016). A few
examples that we have begun to explore are listed below.
In the pineal gland, adrenergic receptor activity is coupled to
cyclic GMP synthesis by ROS-GC1 and changes in intracellular
Ca2+ via S100B (Venkataraman et al., 1998). GCAP1 expression
in the pineal gland raised the possibility for another bimodal
switch like that present in photoreceptor-bipolar cell synapses
(Venkataraman et al., 2000). However, immunohistochemical
analyses distinguish two types of pinealocytes, one that is
GCAP1-modulated and another that is S100B-modulated.
Therefore, bimodal switching is precluded in this system. ANF,
CNP and CNP-RGC are also expressed in pinealocytes (Olcese
et al., 1994; Middendorff et al., 1996).
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FIGURE 10 | Ubiquitous expression of MGC signaling systems. MGCs is a multi-switching cyclic GMP generating machine linked with the physiology of
cardio-vasculature, smooth muscle relaxation, sensory transduction, neuronal plasticity and memory in mammalian neurosensory, endocrine and peripheral tissues.
Reproduced from Sharma et al. (2015).
Expression of a Ca2+ signaling MGC transduction system
in the anterior portion of the bovine gustatory epithelium has
been demonstrated at the biochemical, molecular and functional
levels, implicating a role in taste (Duda and Sharma, 2004). The
system is composed of two components: the Ca2+-sensor protein,
S100B and the transducer, ROS-GC1. Co-immunoprecipitation
experiments reveal that ROS-GC1 and S100B physically interact
with each other. The precise operational mechanism of this
signal transduction mechanism has not yet been decoded at the
physiological level.
Dissection and reconstitution of the biochemical and
functional components of the rat olfactory bulb demonstrate that
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FIGURE 11 | Multiple modulators of ROS-GC1 catalytic activity. ROS-GC is a multi-switch transduction unit with a site for HCO3− and Ca2+ sensor switching
domains for GCAP1 and 2, S100B and NCδ. The sites for Frq and Hpca binding are not known, but based on studies with ONE-GC, the site for Frq is likely to be
located in the CCD. This architecture provides it with cellular signaling specificity and elasticity in a variety of tissues.
a GCAP1-modulated ROS-GC1 transduction system is present in
its mitral cells. At the biochemical level, the machinery functions
according to the principles established for phototransduction.
Olfactory bulb ROS-GC1 senses free levels of Ca2+ via GCAP1
with an IC50 of 70 nM. The bulb neurons do not express GCAP2
Ca2+ sensor, nor do they express ROS-GC2. The olfactory bulb
functions as a ‘‘processing unit’’ for post-odorant transduction
events, directing the odorant impulses to the olfactory tract on
their way to cortical centers of the brain for odorant perception
(Figure 6; Duda et al., 2001b).
Numerous studies support second messenger roles for
GMP and for the presence of an ANF-dependent ANF-RGC
transduction system in the physiology of the testes: sperm
motility, development of testicular germ cells, relaxation
of peritubular lamina propia cells, testosterone synthesis in
Leydig cells and dilation of testicular blood vessels (Marala and
Sharma, 1988; Singh et al., 1988; Garbers, 1989; Pandey
and Singh, 1990; Armstrong et al., 1994; Middendorff
et al., 1997, 2000; Pandey et al., 1999; Mourdjeva et al.,
2001).
TABLE 1 | Modulators of membrane guanylate cyclase (MGC) activity.
Receptor Ligands: Orthosteric, Allosteric P© Ca2+ Sensor
Type Alias Agonists ATP HCO−3 GCAP1 GCAP2 S100B NCδ Frq Hpca VILIP-1
ANF-RGC GC-A ANF, BNP + -? + x X
CNP-RGC GC-B CNP + x + X
STa-RGC GC-C STa, guanylin, uroguanylin + x -
ONE-GC GC-D uroguanylin + X X X X
ROS-GC1 GC-E orphan + + + X X X X X X
ROS-GC2 GC-F orphan + x X x x x x
GC-G TMT, DMP? +
Abbreviations for ligands: ANF, atrial natriuretic factor; BNP, brain natriuretic peptide; CNP, C-type natriuretic peptide; STa, heat stable bacterial enterotoxin; TMT,
2,4,5-trimethylthiazoline; DMP, 2,3-dimethylpyrazine. The evidence supporting DMP as an agonist for GC-G is indirect. P© refers to phosphorylation of Ser and Thr
residues, except for GC-C, where Tyr phosphorylation reduces STa-induced activity. For the effect of ATP, HCO−3 and P©, “+” indicates an increase in activity or a
requirement for orthosteric agonist-induced activity, “−” indicates a decrease in activity. Bicarbonate decreases GC-A activity when expressed in CHO but not when
expressed in E. coli or in HEK-293T. A “X” means that the Ca2+ sensor has an effect on the activity of the MGC; an “x” means that it has no effect. In general, Ca2+
sensors stimulate MGCs when Ca2+ is bound. The notable exception is that for ROS-GCs, GCAPs stimulate at low Ca2+ and inhibit at high Ca2+. In some cases, the
interactions were tested in a recombinant system so the coupling may not exist in vivo.
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Biochemical studies demonstrate a ROS-GC1 transduction
systemmodulated by GCAP1 and S100B in plasma membrane of
bovine testes (Jankowska et al., 2007, 2014). Immuno-stainings
establish that these components co-localize in bovine and
human sperm (Jankowska and Warchol, 2010). A convergence
of molecular genetics, biochemistry and immunohistochemistry
disclose NCδ in male gonads (Jankowska et al., 2014). Thus,
three sensors: GCAP1, S100B and NCδ, capture and transmit
Ca2+ signals to ROS-GC1 in this tissue. The transduction unit
is expressed in all germinal cell types of the human testes:
spermatogonias, spermatocytes, and spermatids. The spermatids
residing close to the seminiferous tubule lumen embody the
abundance of the transduction unit, suggesting involvement with
the processes of spermatogenesis. Based on mouse-KO models,
NCδ is the major (75%) and S100B the minor (25%) contributor
of Ca2+ signaling by ROS-GC1. The contribution of GCAP1 has
not been determined but there is evidence for bimodal Ca2+
operation in bovine and human spermatozoa (Jankowska and
Warchol, 2010). Guanylate cyclase activity is minimal at 800 nM,
but increases with a decline in Ca2+ with an IC50 of 200 nM
and increases as Ca2+ is raised with an EC50 of 2 µM. GC-G
expression inmouse sperm (Kuhn et al., 2004; Huang et al., 2006)
could support thermotaxis and/or chemotaxis and contribute to
the bicarbonate sensitivity. The homologous human gene is also
expressed in sperm, yet it does not encode a true MGC because
of termination codons in the KHD.
CONCLUSIONS
This monograph narrates an extraordinary tale of MGCs. It
started about four decades ago, when the authors’ group made
a key observation that a novel, epinephrine-sensitive MGC
transduction system existed in rat adrenocortical carcinoma
494 cells that is absent from the normal adrenal cortex
(Perchellet and Sharma, 1980; Shanker and Sharma, 1980).
Over the ensuing years meticulous dissection of the MGC
system resulted in its rise from anonymity to its present
status as a preeminent cellular signal transducer generating
the intracellular second messenger, cyclic GMP, to critically
control countless physiological processes, including cardiac
vascular tension, smooth muscle relaxation, blood volume,
cellular growth, sensory transduction, neural plasticity, learning
and memory (Figure 10).
How does it perform such diverse tasks? A modular structure
makes the MGC extremely flexible and multimodal. Unlike the
three-component design of its predecessor second messenger
systems: adenylate cyclase and IP3, G-protein and G-protein
coupled receptors; the MGC transduction system consists of a
single entity, a trans-membrane-spanning protein that serves as
both a receptor and a signal transducer. For all MGCs except for
ROS-GC1 and 2, the ExtD binds hormones or small molecules.
SomeMGCs have subunits that attach to an intracellular domain
(ICD) and confer Ca2+ sensitivity. The relation between Ca2+
and MGC activity is variable. With ANF-RGC, high Ca2+
stimulates activity without ligand binding whereas ROS-GC1 and
ONE-GC can act as bimodal Ca2+ switches; activity is maximal
as Ca2+ is depleted, it subsides at midrange [Ca2+]i, then rises
once again as [Ca2+] reaches its highest levels. The basis for
these different modes of action trace to the identity of the Ca2+
sensor involved: GCAPs, S100B, neurocalcin, frequenin. In a
startling arrangement, the conduct of GCAP1 depends upon its
MGC partner; it stimulates ROS-GCs at low Ca2+ and inhibits
them at high Ca2+, but stimulates ONE-GC at high Ca2+. ROS-
GC1 is capable of coupling with many different Ca2+ sensors
(Figure 11), in part because of its CTE. In contrast, ROS-GC2
is quite selective even though it also has a CTE. Interestingly,
the expansiveness of CTE in STa-RGC and in GC-G raises the
question as to what other functions this structure performs. It
is now recognized that the conserved CCD dimer is receptive to
signals generated by both C-terminal and N-terminal modular
blocks. In an extraordinary development, the CCD is also
subject to direct tuning by Ca2+/neurocalcin and by bicarbonate.
With conservation of the CCD, nearly every MGC responds
to bicarbonate. The response of ROS-GC to bicarbonate and
Ca2+-modulated GCAPs and S100B in combination exceeds the
sum of the individual modulations affording a means to amplify
the transductions. It remains to be seen whether bicarbonate
can also amplify transduction of orthosteric ligand binding.
Chemical modulation and regulation by phosphorylation of
MGCs are summarized in Table 1. Besides sensing odorants
and bicarbonate and Ca2+, GC-G has evolved a remarkable
mechanism whereby dimerization and catalytic activity are
maximal at a particular temperature in order to sense mild
cooling. These transductions encroach on territories of GPCRs
and TRP channels. In the former case, MGCs may provide for
faster signaling and in the latter, case, amplification. The growing
appreciation for MGC signaling throughout the body calls for
reclassification of their Ca2+ sensors. NCδ and GCAPs can no
longer be considered as strictly NCSs, as their expression is more
widespread.
NOMENCLATURE
The reasoning for usage of the present nomenclature for the
subtypes ofMGCswas explained in our previous review (Sharma,
2010): ‘‘From its inception to its first discovery this enzyme
has been termed ‘guanylate cyclase’. . . For unknown reasons
some investigators, subsequently, have changed its name to
‘guanylyl cyclase’. The guanylate cyclases ANF-RGC, CNP-RGC
and STa-RGC have been alternately named as GC-A, GC-B
and GC-C, respectively; and ONE-GC, ROS-GC1 and ROS-GC2
as GC-D, GC-E and GC-F, respectively. This investigator has
preferred the former functional nomenclature of the guanylate
cyclases.’’
AUTHOR CONTRIBUTIONS
All authors contributed in the organization, design and writing.
ACKNOWLEDGMENTS
Funding was provided in part by the National Eye Institute
(Grant no. EY023980), but the contents of this article are the
sole responsibility of the authors and do not necessarily reflect
Frontiers in Molecular Neuroscience | www.frontiersin.org 17 September 2016 | Volume 9 | Article 83
Sharma et al. Membrane Guanylate Cyclase Networks
the official views of the National Eye Institute. The authors
gratefully acknowledge past support by numerous USPHS
awards from the National Institutes of Health, the National
Science Foundation and the Damon Runyon Walter Winchell
Cancer Fund, the dedicated work of numerous postdoctoral
fellows and graduate students, and wonderful collaborations with
Drs. Ari Sitaramayya, Karl-W. Koch, Wolfgang Baehr, Anuradha
Krishnan and Venkat Venkataraman.
REFERENCES
Ahrens, H., Paul, A. K., Kuroda, Y., and Sharma, R. K. (1982). Adrenocortical
cyclic GMP-dependent protein kinase: purification, characterization and
modification of its activity by calmodulin and its relationship with
steroidogenesis. Arch. Biochem. Biophys. 215, 597–609. doi: 10.1016/0003-
9861(82)90121-7
Allerston, C. K., von Delft, F., and Gileadi, O. (2013). Crystal structures of the
catalytic domain of human soluble guanylate cyclase. PLoS One 8:e57644.
doi: 10.1371/journal.pone.0057644
Aoki, H., Richmond, M., Izumo, S., and Sadoshima, J. (2000). Specific role of the
extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac
hypertrophy in vitro. Biochem. J. 347, 275–284. doi: 10.1042/bj3470275
Aparicio, J. G., and Applebury, M. L. (1996). The photoreceptor guanylate cyclase
is an autophosphorylating protein kinase. J. Biol. Chem. 271, 27083–27089.
doi: 10.1074/jbc.271.43.27083
Armstrong, V. L., Clulow, J., Murdoch, R. N., and Jones, R. C. (1994). Intracellular
signal transduction mechanisms of rat epididymal spermatozoa and their
relationship to motility and metabolism. Mol. Reprod. Dev. 38, 77–84. doi: 10.
1002/mrd.1080380113
Ashman, D. F., Lipton, R., Melicow, M. M., and Price, T. D. (1963). Isolation of
adenosine 3′, 5′-monophosphate and guanosine 3′, 5′-monophosphate from
rat urine. Biochem. Biophys. Res. Commun. 11, 330–334. doi: 10.1016/0006-
291x(63)90566-7
Baehr, W., Karan, S., Maeda, T., Luo, D. G., Li, S., Bronson, J. D., et al. (2007).
The function of guanylate cyclase 1 and guanylate cyclase 2 in rod and cone
photoreceptors. J. Biol. Chem. 282, 8837–8847. doi: 10.1074/jbc.m610369200
Ballermann, B. J., Marala, R. B., and Sharma, R. K. (1988). Characterization and
regulation by protein kinase C of renal glomerular atrial natriuretic peptide
receptor-coupled guanylate cyclase. Biochem. Biophys. Res. Commun. 157,
755–761. doi: 10.1016/s0006-291x(88)80314-0
Barmashenko, G., Buttgereit, J., Herring, N., Bader, M., Ozcelik, C., Manahan-
Vaughan, D., et al. (2014). Regulation of hippocampal synaptic plasticity
thresholds and changes in exploratory and learning behavior in dominant
negative NPR-B mutant rats. Front. Mol. Neurosci. 7:95. doi: 10.3389/fnmol.
2014.00095
Belluscio, L., Gold, G. H., Nemes, A., and Axel, R. (1998). Mice deficient in G(olf)
are anosmic. Neuron 20, 69–81. doi: 10.1016/s0896-6273(00)80435-3
Bereta, G., Wang, B., Kiser, P. D., Baehr, W., Jang, G. F., and Palczewski, K.
(2010). A functional kinase homology domain is essential for the activity of
photoreceptor guanylate cyclase 1. J. Biol. Chem. 285, 1899–1908. doi: 10.
1074/jbc.m109.061713
Bhandari, R., Srinivasan, N., Mahaboobi, M., Ghanekar, Y., Suguna, K., and
Visweswariah, S. S. (2001). Functional inactivation of the human guanylyl
cyclase C receptor: modeling and mutation of the protein kinase-like domain.
Biochemistry 40, 9196–9206. doi: 10.1021/bi002595g
Bourne, Y., Dannenberg, J., Pollmann, V., Marchot, P., and Pongs, O. (2001).
Immunocytochemical localization and crystal structure of human frequenin
(neuronal calcium sensor 1). J. Biol. Chem. 276, 11949–11955. doi: 10.1074/jbc.
M009373200
Bowyer, F., and Kitabchi, A. E. (1974). Dual role of calcium in steroidogenesis in
the isolated adrenal cell of rat. Biochem. Biophys. Res. Commun. 57, 100–105.
doi: 10.1016/s0006-291x(74)80362-1
Braunewell, K. H., Brackmann, M., Schaupp, M., Spilker, C., Anand, R., and
Gundelfinger, E. D. (2001). Intracellular neuronal calcium sensor (NCS)
protein VILIP-1 modulates cGMP signalling pathways in transfected neural
cells and cerebellar granule neurones. J. Neurochem. 78, 1277–1286. doi: 10.
1046/j.1471-4159.2001.00506.x
Braunewell, K. H., and Gundelfinger, E. D. (1999). Intracellular neuronal calcium
sensor proteins: a family of EF-hand calcium-binding proteins in search of a
function. Cell Tissue Res. 295, 1–12. doi: 10.1007/s004410051207
Breer, H. (2003). Olfactory receptors: molecular basis for recognition and
discrimination of odors. Anal. Bioanal. Chem. 377, 427–433. doi: 10.
1007/s00216-003-2113-9
Buck, L. B. (1995). Unraveling chemosensory diversity. Cell 83, 349–352. doi: 10.
1016/0092-8674(95)90110-8
Burgoyne, R. D., and Weiss, J. L. (2001). The neuronal calcium sensor family of
Ca2+-binding proteins. Biochem. J. 353, 1–12. doi: 10.1042/bj3530001
Burnett, J. C. Jr., Granger, J. P., and Opgenorth, T. J. (1984). Effects of synthetic
atrial natriuretic factor on renal function and renin release. Am. J. Physiol. 247,
F863–F866.
Chang, M. S., Lowe, D. G., Lewis, M., Hellmiss, R., Chen, E., and Goeddel, D. V.
(1989). Differential activation by atrial and brain natriuretic peptides of two
different receptor guanylate cyclases.Nature 341, 68–72. doi: 10.1038/341068a0
Chao, Y. C., Cheng, C. J., Hsieh, H. T., Lin, C. C., Chen, C. C., and Yang, R. B.
(2010). Guanylate cyclase-G, expressed in the Grueneberg ganglion olfactory
subsystem, is activated by bicarbonate. Biochem. J. 432, 267–273. doi: 10.
1042/bj20100617
Chao, Y. C., Chen, C. C., Lin, Y. C., Breer, H., Fleischer, J., and Yang, R. B. (2015).
Receptor guanylyl cyclase-G is a novel thermosensory protein activated by cool
temperatures. EMBO J. 34, 294–306. doi: 10.15252/embj.201489652
Chinkers, M., and Garbers, D. L. (1989). The protein kinase domain of the ANP
receptor is required for signaling. Science 245, 1392–1394. doi: 10.1126/science.
2571188
Chinkers, M., Garbers, D. L., Chang, M. S., Lowe, D. G., Chin, H. M.,
Goeddel, D. V., et al. (1989). A membrane form of guanylate cyclase is
an atrial natriuretic peptide receptor. Nature 338, 78–83. doi: 10.1038/33
8078a0
Chinkers, M., Singh, S., and Garbers, D. L. (1991). Adenine nucleotides are
required for activation of rat atrial natriuretic peptide receptor/guanylyl cyclase
expressed in a baculovirus system. J. Biol. Chem. 266, 4088–4093.
Cooper, N., Liu, L., Yoshida, A., Pozdnyakov, N., Margulis, A., and Sitaramayya, A.
(1995). The bovine rod outer segment guanylate cyclase, ROS-GC, is present
in both outer segment and synaptic layers of the retina. J. Mol. Neurosci. 6,
211–222. doi: 10.1007/bf02736766
Cuenca, N., Lopez, S., Howes, K., and Kolb, H. (1998). The localization of guanylyl
cyclase-activating proteins in the mammalian retina. Invest. Ophthalmol. Vis.
Sci. 39, 1243–1250.
De Castro, E., Nef, S., Fiumelli, H., Lenz, S. E., Kawamura, S., and Nef, P. (1995).
Regulation of rhodopsin phosphorylation by a family of neuronal calcium
sensors. Biochem. Biophys. Res. Commun. 216, 133–140. doi: 10.1006/bbrc.
1995.2601
Denninger, J. W., and Marletta, M. A. (1999). Guanylate cyclase and the
NO/cGMP signaling pathway. Biochim. Biophys. Acta 1411, 334–350. doi: 10.
1016/s0005-2728(99)00024-9
Dizhoor, A. M., and Hurley, J. B. (1996). Inactivation of EF-hands makes
GCAP-2 (p24) a constitutive activator of photoreceptor guanylyl cyclase by
preventing a Ca2+-induced ‘‘activator-to-inhibitor’’ transition. J. Biol. Chem.
271, 19346–19350. doi: 10.1074/jbc.271.32.19346
Dizhoor, A. M., Olshevskaya, E. V., Henzel, W. J., Wong, S. C., Stults, J. T.,
Ankoudinova, I., et al. (1995). Cloning, sequencing and expression of a 24-kDa
Ca2+-binding protein activating photoreceptor guanylyl cyclase. J. Biol. Chem.
270, 25200–25206. doi: 10.1074/jbc.270.42.25200
Donaldson, C., Barber, K. R., Kay, C. M., and Shaw, G. S. (1995). Human S100b
protein: formation of a tetramer from synthetic calcium-binding site peptides.
Protein Sci. 4, 765–772. doi: 10.1002/pro.5560040416
Duda, T., Bharill, S., Wojtas, I., Yadav, P., Gryczynski, I., Gryczynski, Z., et al.
(2009). Atrial natriuretic factor receptor guanylate cyclase signaling: new
ATP-regulated transduction motif. Mol. Cell. Biochem. 324, 39–53. doi: 10.
1007/s11010-008-9983-2
Duda, T., Fik-Rymarkiewicz, E., Venkataraman, V., Krishnan, A., and
Sharma, R. K. (2004). Calcium-modulated ciliary membrane guanylate
Frontiers in Molecular Neuroscience | www.frontiersin.org 18 September 2016 | Volume 9 | Article 83
Sharma et al. Membrane Guanylate Cyclase Networks
cyclase transduction machinery: constitution and operational principles.
Mol. Cell. Biochem. 267, 107–122. doi: 10.1023/b:mcbi.0000049372.
33965.4f
Duda, T., Fik-Rymarkiewicz, E., Venkataraman, V., Krishnan, R., Koch, K.W., and
Sharma, R. K. (2005a). The calcium-sensor guanylate cyclase activating protein
type 2 specific site in rod outer segment membrane guanylate cyclase type 1.
Biochemistry 44, 7336–7345. doi: 10.1021/bi050068x
Duda, T., Venkataraman, V., Ravichandran, S., and Sharma, R. K. (2005b). ATP-
regulated module (ARM) of the atrial natriuretic factor receptor guanylate
cyclase. Peptides 26, 969–984. doi: 10.1016/j.peptides.2004.08.032
Duda, T., Goraczniak, R. M., and Sharma, R. K. (1991). Site-directed mutational
analysis of a membrane guanylate cyclase cDNA reveals the atrial natriuretic
factor signaling site. Proc. Natl. Acad. Sci. U S A 88, 7882–7886. doi: 10.
1073/pnas.88.17.7882
Duda, T., Goraczniak, R. M., and Sharma, R. K. (1993a). Core sequence of ATP
regulatory module in receptor guanylate cyclases. FEBS Lett. 315, 143–148.
doi: 10.1016/0014-5793(93)81151-o
Duda, T., Goraczniak, R. M., and Sharma, R. K. (1993b). The glycine residue
of ATP regulatory module in receptor guanylate cyclases that is essential
in natriuretic factor signaling. FEBS Lett. 335, 309–314. doi: 10.1016/0014-
5793(93)80408-m
Duda, T., Goraczniak, R. M., Sitaramayya, A., and Sharma, R. K. (1993c).
Cloning and expression of an ATP-regulated human retina C-type natriuretic
factor receptor guanylate cyclase. Biochemistry 32, 1391–1395. doi: 10.
1021/bi00057a001
Duda, T., Goraczniak, R. M., and Sharma, R. K. (1994). Glutamic acid-332 residue
of the type C natriuretic peptide receptor guanylate cyclase is important for
signaling. Biochemistry 33, 7430–7433. doi: 10.1021/bi00189a050
Duda, T., Goraczniak, R. M., and Sharma, R. K. (1995). Single amino acid
residue-linked signaling shifts in the transduction activities of atrial and type C
natriuretic factor receptor guanylate cyclases. Biochem. Biophys. Res. Commun.
212, 1046–1053. doi: 10.1006/bbrc.1995.2075
Duda, T., Goraczniak, R. M., and Sharma, R. K. (1996a). Molecular
characterization of S100A1–S100B protein in retina and its activation
mechanism of bovine photoreceptor guanylate cyclase. Biochemistry 35,
6263–6266. doi: 10.1021/bi960007m
Duda, T., Goraczniak, R., Surgucheva, I., Rudnicka-Nawrot, M., Gorczyca, W. A.,
Palczewski, K., et al. (1996b). Calcium modulation of bovine photoreceptor
guanylate cyclase. Biochemistry 35, 8478–8482. doi: 10.1021/bi960752z
Duda, T., Jankowska, A., Venkataraman, V., Nagele, R. G., and Sharma, R. K.
(2001a). A novel calcium-regulated membrane guanylate cyclase transduction
system in the olfactory neuroepithelium. Biochemistry 40, 12067–12077.
doi: 10.1021/bi0108406
Duda, T., Venkataraman, V., Krishnan, A., Nagele, R. G., and Sharma, R. K.
(2001b). Negatively calcium-modulated membrane guanylate cyclase signaling
system in the rat olfactory bulb. Biochemistry 40, 4654–4662. doi: 10.
1021/bi0027985
Duda, T., Yadav, P., Jankowska, A., Venkataraman, V., and Sharma, R. K.
(2001c). Three dimensional atomic model and experimental validation for
the ATP-regulated module (ARM) of the atrial natriuretic factor receptor
guanylate cyclase. Mol. Cell. Biochem. 217, 165–172. doi: 10.1023/A:10072369
17061
Duda, T., Koch, K. W., Venkataraman, V., Lange, C., Beyermann, M., and
Sharma, R. K. (2002). Ca2+ sensor S100 beta-modulated sites of membrane
guanylate cyclase in the photoreceptor-bipolar synapse. EMBO J. 21,
2547–2556. doi: 10.1093/emboj/21.11.2547
Duda, T., Krishnan, R., and Sharma, R. K. (2006). GCAP1 Antithetical calcium
censor of ROS-GC transduction machinery. Calcium Bind. Proteins 1,
102–107.
Duda, T., Pertzev, A., Koch, K. W., and Sharma, R. K. (2012a). Antithetical modes
of and the Ca2+ sensors targeting in ANF-RGC and ROS-GC1 membrane
guanylate cyclases. Front. Mol. Neurosci. 5:44. doi: 10.3389/fnmol.2012.
00044
Duda, T., Pertzev, A., and Sharma, R. K. (2012b). Ca2+ modulation of ANF-
RGC: new signaling paradigm interlocked with blood pressure regulation.
Biochemistry 51, 9394–9405. doi: 10.1021/bi301176c
Duda, T., Pertzev, A., and Sharma, R. K. (2012c). Differential Ca2+ sensor
guanylate cyclase activating protein modes of photoreceptor rod outer segment
membrane guanylate cyclase signaling. Biochemistry 51, 4650–4657. doi: 10.
1021/bi300572w
Duda, T., Pertzev, A., and Sharma, R. K. (2011a). 657WTAPELL663 motif of
the photoreceptor ROS-GC1: a general phototransduction switch. Biochem.
Biophys. Res. Commun. 408, 236–241. doi: 10.1016/j.bbrc.2011.03.134
Duda, T., Yadav, P., and Sharma, R. K. (2011b). Allosteric modification,
the primary ATP activation mechanism of atrial natriuretic factor
receptor guanylate cyclase. Biochemistry 50, 1213–1225. doi: 10.1021/bi10
18978
Duda, T., Pertzev, A., and Sharma, R. K. (2013). The ANF-RGC gene motif
(669)WTAPELL(675) is vital for blood pressure regulation: biochemical
mechanism. Biochemistry 52, 2337–2347. doi: 10.1021/bi400175d
Duda, T., Pertzev, A., and Sharma, R. K. (2014). Atrial natriuretic factor receptor
guanylate cyclase, ANF-RGC, transduces two independent signals, ANF and
Ca2+. Front. Mol. Neurosci. 7:17. doi: 10.3389/fnmol.2014.00017
Duda, T., Pertzev, A., Makino, C. L., and Sharma, R. K. (2016). Bicarbonate
and Ca2+ sensing modulators activate photoreceptor ROS-GC1 synergistically.
Front. Mol. Neurosci. 9:5. doi: 10.3389/fnmol.2016.00005
Duda, T., and Sharma, R. K. (1995a). ATP bimodal switch that regulates the
ligand binding and signal transduction activities of the atrial natriuretic factor
receptor guanylate cyclase. Biochem. Biophys. Res. Commun. 209, 286–292.
doi: 10.1006/bbrc.1995.1501
Duda, T., and Sharma, R. K. (1995b). ATP modulation of the ligand binding
and signal transduction activities of the type C natriuretic peptide receptor
guanylate cyclase. Mol. Cell. Biochem. 152, 179–183. doi: 10.1007/bf010
76081
Duda, T., and Sharma, R. K. (2004). S100B-modulated Ca2+-dependent ROS-
GC1 transduction machinery in the gustatory epithelium: a new mechanism
in gustatory transduction. FEBS Lett. 577, 393–398. doi: 10.1016/j.febslet.2004.
09.089
Duda, T., and Sharma, R. K. (2008). ONE-GC membrane guanylate cyclase, a
trimodal odorant signal transducer. Biochem. Biophys. Res. Commun. 367,
440–445. doi: 10.1016/j.bbrc.2007.12.153
Duda, T., and Sharma, R. K. (2010). Distinct ONE-GC transduction modes and
motifs of the odorants: uroguanylin and CO2. Biochem. Biophys. Res. Commun.
391, 1379–1384. doi: 10.1016/j.bbrc.2009.12.068
Duda, T., Venkataraman, V., Goraczniak, R., Lange, C., Koch, K. W.,
and Sharma, R. K. (1999). Functional consequences of a rod outer
segment membrane guanylate cyclase (ROS-GC1) gene mutation linked with
Leber’s congenital amaurosis. Biochemistry 38, 509–515. doi: 10.1021/bi98
24137
Duda, T., Wen, X. H., Isayama, T., Sharma, R. K., and Makino, C. L.
(2015). Bicarbonate modulates photoreceptor guanylate cyclase (ROS-GC)
catalytic activity. J. Biol. Chem. 290, 11052–11060. doi: 10.1074/jbc.m115.
650408
Duda, T., Yadav, P., Jankowska, A., Venkataraman, V., and Sharma, R. K. (2000).
Three dimensional atomic model and experimental validation for the ATP-
Regulated Module (ARM) of the atrial natriuretic factor receptor guanylate
cyclase.Mol. Cell. Biochem. 214, 7–14. doi: 10.1023/A:1007144328682
Fesenko, E. E., Kolesnikov, S. S., and Lyubarsky, A. L. (1985). Induction by
cyclic GMP of cationic conductance in plasma membrane of retinal rod outer
segment. Nature 313, 310–313. doi: 10.1038/313310a0
Fik-Rymarkiewicz, E., Duda, T., and Sharma, R. K. (2006). Novel frequenin-
modulated Ca2+-signaling membrane guanylate cyclase (ROS-GC)
transduction pathway in bovine hippocampus. Mol. Cell. Biochem. 291,
187–204. doi: 10.1007/s11010-006-9215-6
Fleischer, J., Mamasuew, K., and Breer, H. (2009). Expression of cGMP signaling
elements in the Grueneberg ganglion. Histochem. Cell Biol. 131, 75–88. doi: 10.
1007/s00418-008-0514-8
Frins, S., Bönigk, W., Müller, F., Kellner, R., and Koch, K. W. (1996). Functional
characterization of a guanylyl cyclase-activating protein from vertebrate
rods. Cloning, heterologous expression and localization. J. Biol. Chem. 271,
8022–8027. doi: 10.1074/jbc.271.14.8022
Fulle, H. J., Vassar, R., Foster, D. C., Yang, R. B., Axel, R., andGarbers, D. L. (1995).
A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons.
Proc. Natl. Acad. Sci. U S A 92, 3571–3575. doi: 10.1073/pnas.92.8.3571
Garbers, D. L. (1989). Molecular basis of signalling in the spermatozoon. J. Androl.
10, 99–107. doi: 10.1002/j.1939-4640.1989.tb00068.x
Frontiers in Molecular Neuroscience | www.frontiersin.org 19 September 2016 | Volume 9 | Article 83
Sharma et al. Membrane Guanylate Cyclase Networks
Gill, G. N., and McCune, R. W. (1979). Guanosine 3′,5′-monophosphate-
dependent protein kinase. Curr. Top. Cell. Regul. 15, 1–45. doi: 10.1016/b978-
0-12-152815-7.50005-3
Goldberg, N. D., Dietz, S. B., and O’Toole, A. G. (1969). Cyclic guanosine
3′,5′-monophosphate in mammalian tissues and urine. J. Biol. Chem. 244,
4458–4466.
Goldberg, N. D., and Haddox, M. K. (1977). Cyclic GMP metabolism and
involvement in biological regulation. Annu. Rev. Biochem. 46, 823–896. doi: 10.
1146/annurev.bi.46.070177.004135
Goldberg, N. D., O’Dea, R. F., and Haddox, M. K. (1973). Cyclic GMP. Adv. Cyclic
Nucleotide Res. 3, 155–223.
Goraczniak, R. M., Duda, T., and Sharma, R. K. (1992). A structural motif that
defines the ATP-regulatory module of guanylate cyclase in atrial natriuretic
factor signalling. Biochem. J. 282, 533–537. doi: 10.1042/bj2820533
Goraczniak, R., Duda, T., and Sharma, R. K. (1997). Structural and functional
characterization of a second subfamily member of the calcium-modulated
bovine rod outer segment membrane guanylate cyclase, ROS-GC2. Biochem.
Biophys. Res. Commun. 234, 666–670. doi: 10.1006/bbrc.1997.6579
Goraczniak, R. M., Duda, T., and Sharma, R. K. (1998). Calcium modulated
signaling site in type 2 rod outer segment membrane guanylate cyclase (ROS-
GC2). Biochem. Biophys. Res. Commun. 245, 447–453. doi: 10.1006/bbrc.1998.
8455
Goraczniak, R. M., Duda, T., Sitaramayya, A., and Sharma, R. K. (1994). Structural
and functional characterization of the rod outer segment membrane guanylate
cyclase. Biochem. J. 302, 455–461. doi: 10.1042/bj3020455
Gorczyca, W. A., Polans, A. S., Surgucheva, I. G., Subbaraya, I., Baehr, W., and
Palczewski, K. (1995). Guanylyl cyclase activating protein. A calcium-sensitive
regulator of phototransduction. J. Biol. Chem. 270, 22029–22036. doi: 10.
1074/jbc.270.37.22029
Gorczyca, W. A., Van Hooser, J. P., and Palczewski, K. (1994). Nucleotide
inhibitors and activators of retinal guanylyl cyclase. Biochemistry 33,
3217–3222. doi: 10.1021/bi00177a011
Guo, D., Zhang, J. J., and Huang, X. Y. (2009). Stimulation of guanylyl
cyclase-D by bicarbonate. Biochemistry 48, 4417–4422. doi: 10.1021/bi90
0441v
Haeseleer, F., Sokal, I., Li, N., Pettenati, M., Rao, N., Bronson, D., et al. (1999).
Molecular characterization of a third member of the guanylyl cyclase-activating
protein subfamily. J. Biol. Chem. 274, 6526–6535. doi: 10.1074/jbc.274.
10.6526
Haksar, A., and Péron, F. G. (1973). The role of calcium in the steroidogenic
response of rat adrenal cells to adrenocorticotropic hormone. Biochim. Biophys.
Acta 313, 363–371. doi: 10.1016/0304-4165(73)90036-6
Hardman, J. G., Davis, J. W., and Sutherland, E. W. (1969). Effects of
some hormonal and other factors on the excretion of guanosine 3′,5′-
monophosphate and adenosine 3′,5′-monophosphate in rat urine. J. Biol.
Chem. 244, 6354–6362.
Hardman, J. G., and Sutherland, E. W. (1969). Guanyl cyclase, an enzyme
catalyzing the formation of guanosine 3′,5′-monophosphate from guanosine
triphosphate. J. Biol. Chem. 244, 6363–6370.
Harrington, C. A., Fenimore, D. C., and Farmer, R. W. (1978). Regulation of
adrenocortical steroidogenesis by cyclic 3′-5′-guanosine monophosphate in
isolated rat adrenal cells. Biochem. Biophys. Res. Commun. 85, 55–61. doi: 10.
1016/s0006-291x(78)80010-2
Hayashi, K., Sala, G., Catt, K., and Dufau, M. L. (1979). Regulation of
steroidogenesis by adrenocorticotropic hormone in isolated adrenal cells. The
intermediate role of cyclic nucleotides. J. Biol. Chem. 254, 6678–6683.
Hayashi, F., and Yamazaki, A. (1991). Polymorphism in purified guanylate cyclase
from vertebrate rod photoreceptors. Proc. Natl. Acad. Sci. U S A 88, 4746–4750.
doi: 10.1073/pnas.88.11.4746
He, X.-L., Chow, D.-C., Martick, M. M., and Garcia, K. C. (2001). Allosteric
activation of a spring-loaded natriuretic peptide receptor dimer by hormone.
Science 293, 1657–1662. doi: 10.1126/science.1062246
Hendricks, K. B., Wang, B. Q., Schnieders, E. A., and Thorner, J. (1999). Yeast
homologue of neuronal frequenin is a regulator of phosphatidylinositol-4-OH
kinase. Nat. Cell Biol. 1, 234–241. doi: 10.1038/12058
Herman, J. P., Dolgas, C. M., Rucker, D., and Langub, M. C. Jr. (1996).
Localization of natriuretic peptide-activated guanylate cyclase mRNAs in
the rat brain. J. Comp. Neurol. 369, 165–187. doi: 10.1002/(SICI)1096-
9861(19960527)369:2<165::AID-CNE1>3.0.CO;2-1
Horio, Y., and Murad, F. (1991a). Purification of guanylyl cyclase from rod
outer segments. Biochim. Biophys. Acta 1133, 81–88. doi: 10.1016/0167-
4889(91)90244-r
Horio, Y., and Murad, F. (1991b). Solubilization of guanylyl cyclase from bovine
rod outer segments and effects of lowering Ca2+ and nitro compounds. J. Biol.
Chem. 266, 3411–3415.
Hu, J., Zhong, C., Ding, C., Chi, Q., Walz, A., Mombaerts, P., et al. (2007).
Detection of near-atmospheric concentrations of CO2 by an olfactory
subsystem in the mouse. Science 317, 953–957. doi: 10.1126/science.1144233
Huang, Y. H., Wei, C. C., Su, Y. H., Wu, B. T., Ciou, Y. Y., Tu, C. F., et al. (2006).
Localization and characterization of an orphan receptor, guanylyl cyclase-G, in
mouse testis and sperm. Endocrinology 147, 4792–4800. doi: 10.1210/en.2005-
1476
Hwang, J. Y., Lange, C., Helten, A., Hoppner-Heitmann, D., Duda, T.,
Sharma, R. K., et al. (2003). Regulatory modes of rod outer segment membrane
guanylate cyclase differ in catalytic efficiency and Ca2+-sensitivity. Eur. J.
Biochem. 270, 3814–3821. doi: 10.1046/j.1432-1033.2003.03770.x
Ignarro, L. J., Degnan, J. N., Baricos, W. H., Kadowitz, P. J., and Wolin, M. S.
(1982a). Activation of purified guanylate cyclase by nitric oxide requires heme.
Comparison of heme-deficient, heme-reconstituted and heme-containing
forms of soluble enzyme from bovine lung. Biochim. Biophys. Acta 718, 49–59.
doi: 10.1016/0304-4165(82)90008-3
Ignarro, L. J., Wood, K. S., and Wolin, M. S. (1982b). Activation of purified
soluble guanylate cyclase by protoporphyrin IX. Proc. Natl. Acad. Sci. U S A
79, 2870–2873. doi: 10.1073/pnas.79.9.2870
Ishikawa, E., Ishikawa, S., Davis, J. W., and Sutherland, E. W. (1969).
Determination of guanosine 3′,5′-monophosphate in tissues and of guanyl
cyclase in rat intestine. J. Biol. Chem. 244, 6371–6376.
Jaiswal, N., Paul, A. K., Jaiswal, R. K., and Sharma, R. K. (1986). Atrial natriuretic
factor regulation of cyclic GMP levels and steroidogenesis in isolated fasciculata
cells of rat adrenal cortex. FEBS Lett. 199, 121–124. doi: 10.1016/0014-
5793(86)81236-4
Jaiswal, N., and Sharma, R. K. (1986). Dual regulation of adenylate cyclase and
guanylate cyclase: alpha 2-adrenergic signal transduction in adrenocortical
carcinoma cells. Arch. Biochem. Biophys. 249, 616–619. doi: 10.1016/0003-
9861(86)90041-x
Jaleel, M., Saha, S., Shenoy, A. R., and Visweswariah, S. S. (2006). The
kinase homology domain of receptor guanylyl cyclase C: ATP binding
and identification of an adenine nucleotide sensitive site. Biochemistry 45,
1888–1898. doi: 10.1021/bi052089x
Jankowska, A., Burczynska, B., Duda, T., Warchol, J. B., and Sharma, R. K. (2007).
Calcium-modulated rod outer segment membrane guanylate cyclase type 1
transduction machinery in the testes. J. Androl. 28, 50–58. doi: 10.2164/jandrol.
106.000182
Jankowska, A., Sharma, R. K., and Duda, T. (2014). Ca2+-modulated ROS-GC1
transduction system in testes and its presence in the spermatogenic cells. Front.
Mol. Neurosci. 7:34. doi: 10.3389/fnmol.2014.00034
Jankowska, A., and Warchol, J. B. (2010). Ca2+-modulated membrane guanylate
cyclase in the testes. Mol. Cell. Biochem. 334, 169–179. doi: 10.1007/s11010-
009-0329-5
Jeromin, A., Shayan, A. J., Msghina, M., Roder, J., and Atwood, H. L. (1999).
Crustacean frequenins: molecular cloning and differential localization at
neuromuscular junctions. J. Neurobiol. 41, 165–175. doi: 10.1002/(SICI)1097-
4695(19991105)41:2<165::AID-NEU1>3.0.CO;2-9
Jewett, J. R., Koller, K. J., Goeddel, D. V., and Lowe, D. G. (1993).
Hormonal induction of low affinity receptor guanylyl cyclase. EMBO J. 12,
769–777.
Juilfs, D. M., Fulle, H. J., Zhao, A. Z., Houslay, M. D., Garbers, D. L., and
Beavo, J. A. (1997). A subset of olfactory neurons that selectively express
cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a
unique olfactory signal transduction pathway. Proc. Natl. Acad. Sci. U S A 94,
3388–3395. doi: 10.1073/pnas.94.7.3388
Kachi, S., Nishizawa, Y., Olshevskaya, E., Yamazaki, A., Miyake, Y.,
Wakabayashi, T., et al. (1999). Detailed localization of photoreceptor
guanylate cyclase activating protein-1 and -2 in mammalian retinas using light
and electron microscopy. Exp. Eye Res. 68, 465–473. doi: 10.1006/exer.1998.
0629
Kitabchi, A. E.,Wilson, D. B., and Sharma, R. K. (1971). Steroidogenesis in isolated
adrenal cells of rat. II. Effect of caffeine on ACTH and cyclic nucleotide-
Frontiers in Molecular Neuroscience | www.frontiersin.org 20 September 2016 | Volume 9 | Article 83
Sharma et al. Membrane Guanylate Cyclase Networks
induced steroidogenesis and its relation to cyclic nucleotide phosphodiesterase
(PDE). Biochem. Biophys. Res. Commun. 44, 898–904. doi: 10.1016/0006-
291X(71)90796-0
Koch, K. W. (1991). Purification and identification of photoreceptor guanylate
cyclase. J. Biol. Chem. 266, 8634–8637.
Koch, K. W., and Dell’Orco, D. (2013). A calcium-relay mechanism in vertebrate
phototransduction. ACS Chem. Neurosci. 4, 909–917. doi: 10.1021/cn
400027z
Koch, K. W., and Dell’Orco, D. (2015). Protein and signaling networks in
vertebrate photoreceptor cells. Front. Mol. Neurosci. 8:67. doi: 10.3389/fnmol.
2015.00067
Koch, K. W., Duda, T., and Sharma, R. K. (2010). Ca2+-modulated vision-linked
ROS-GC guanylate cyclase transduction machinery. Mol. Cell. Biochem. 334,
105–115. doi: 10.1007/s11010-009-0330-z
Koch, K. W., and Stryer, L. (1988). Highly cooperative feedback control of
retinal rod guanylate cyclase by calcium ions. Nature 334, 64–66. doi: 10.
1038/334064a0
Koller, K. J., de Sauvage, F. J., Lowe, D. G., and Goeddel, D. V. (1992).
Conservation of the kinaselike regulatory domain is essential for activation
of the natriuretic peptide receptor guanylyl cyclases. Mol. Cell. Biol. 12,
2581–2590. doi: 10.1128/mcb.12.6.2581
Krishnan, A., Duda, T., Pertzev, A., Kobayashi, M., Takamatsu, K., and
Sharma, R. K. (2009). Hippocalcin, new Ca2+ sensor of a ROS-GC subfamily
member, ONE-GC, membrane guanylate cyclase transduction system. Mol.
Cell. Biochem. 325, 1–14. doi: 10.1007/s11010-008-0015-z
Krishnan, A., Goraczniak, R. M., Duda, T., and Sharma, R. K. (1998).
Third calcium-modulated rod outer segment membrane guanylate cyclase
transduction mechanism. Mol. Cell. Biochem. 178, 251–259. doi: 10.
1023/A:1006860018300
Krishnan, A., Venkataraman, V., Fik-Rymarkiewicz, E., Duda, T., and
Sharma, R. K. (2004). Structural, biochemical and functional characterization
of the calcium sensor neurocalcin delta in the inner retinal neurons and its
linkage with the rod outer segment membrane guanylate cyclase transduction
system. Biochemistry 43, 2708–2723. doi: 10.1021/bi035631v
Kuhn, M. (2016). Molecular physiology of membrane guanylyl cyclase receptors.
Physiol. Rev. 96, 751–804. doi: 10.1152/physrev.00022.2015
Kuhn, M., Ng, C. K., Su, Y. H., Kilic´, A., Mitko, D., Bien-Ly, N., et al. (2004).
Identification of an orphan guanylate cyclase receptor selectively expressed in
mouse testis. Biochem. J. 379, 385–393. doi: 10.1042/bj20031624
Kumar, V. D., Vijay-Kumar, S., Krishnan, A., Duda, T., and Sharma, R. K. (1999).
A second calcium regulator of rod outer segment membrane guanylate cyclase,
ROS-GC1: neurocalcin. Biochemistry 38, 12614–12620. doi: 10.1021/bi990851n
Ladant, D. (1995). Calcium and membrane binding properties of bovine
neurocalcin delta expressed in Escherichia coli. J. Biol. Chem. 270,
3179–3185.
Lai, P. C., Singer, M. S., and Crasto, C. J. (2005). Structural activation pathways
from dynamic olfactory receptor-odorant interactions. Chem. Senses 30,
781–792. doi: 10.1093/chemse/bji070
Lange, C., Duda, T., Beyermann, M., Sharma, R. K., and Koch, K. W. (1999).
Regions in vertebrate photoreceptor guanylyl cyclase ROS-GC1 involved in
Ca2+-dependent regulation by guanylyl cyclase-activating protein GCAP-1.
FEBS Lett. 460, 27–31. doi: 10.1016/s0014-5793(99)01312-5
Langub, M. C. Jr., Watson, R. E. Jr., and Herman, J. P. (1995). Distribution of
natriuretic peptide precursor mRNAs in the rat brain. J. Comp. Neurol. 356,
183–199. doi: 10.1002/cne.903560205
Larose, L., McNicoll, N., Ong, H., and De Léan, A. (1991). Allosteric modulation
by ATP of the bovine adrenal natriuretic factor R1 receptor functions.
Biochemistry 30, 8990–8995. doi: 10.1021/bi00101a012
Laychock, S. G., and Hardman, J. G. (1978). Effects of sodium nitroprusside
and ascorbic acid on rat adrenocortical cell cGMP levels and steroidogenesis.
J. Cyclic Nucleotide Res. 4, 335–344.
Leinders-Zufall, T., Cockerham, R. E., Michalakis, S., Biel, M., Garbers, D. L.,
Reed, R. R., et al. (2007). Contribution of the receptor guanylyl cyclase GC-D
to chemosensory function in the olfactory epithelium. Proc. Natl. Acad. Sci. U
S A 104, 14507–14512. doi: 10.1073/pnas.0704965104
Lim, S., Dizhoor, A. M., and Ames, J. B. (2014). Structural diversity of neuronal
calcium sensor proteins and insights for activation of retinal guanylyl cyclase
by GCAP1. Front. Mol. Neurosci. 7:19. doi: 10.3389/fnmol.2014.00019
Lim, S., Strahl, T., Thorner, J., and Ames, J. B. (2011). Structure of a Ca2+-
myristoyl switch protein that controls activation of a phosphatidylinositol
4-kinase in fission yeast. J. Biol. Chem. 286, 12565–12577. doi: 10.1074/jbc.
M110.208868
Liu, X., Seno, K., Nishizawa, Y., Hayashi, F., Yamazaki, A., Matsumoto, H., et al.
(1994). Ultrastructural localization of retinal guanylate cyclase in human and
monkey retinas. Exp. Eye Res. 59, 761–768. doi: 10.1006/exer.1994.1162
Lowe, D. G., Chang, M. S., Hellmiss, R., Chen, E., Singh, S., Garbers, D. L., et al.
(1989). Human atrial natriuretic peptide receptor defines a new paradigm for
second messenger signal transduction. EMBO J. 8, 1377–1384.
Lowe, D. G., Dizhoor, A. M., Liu, K., Gu, Q., Spencer, M., Laura, R., et al. (1995).
Cloning and expression of a second photoreceptor-specific membrane retina
guanylyl cyclase (RetGC), RetGC-2. Proc. Natl. Acad. Sci. U S A 92, 5535–5539.
doi: 10.1073/pnas.92.12.5535
Makino, C. L., Peshenko, I. V., Wen, X. H., Olshevskaya, E. V., Barrett, R., and
Dizhoor, A. M. (2008). A role for GCAP2 in regulating the photoresponse.
Guanylyl cyclase activation and rod electrophysiology in GUCA1B knock-out
mice. J. Biol. Chem. 283, 29135–29143. doi: 10.1074/jbc.M804445200
Makino, C. L., Wen, X. H., Olshevskaya, E. V., Peshenko, I. V., Savchenko, A. B.,
and Dizhoor, A. M. (2012). Enzymatic relay mechanism stimulates cyclic
GMP synthesis in rod photoresponse: biochemical and physiological study
in guanylyl cyclase activating protein 1 knockout mice. PLoS One 7:e47637.
doi: 10.1371/journal.pone.0047637
Marala, R., Duda, T., Goraczniak, R. M., and Sharma, R. K. (1992). Genetically
tailored atrial natriuretic factor-dependent guanylate cyclase. Immunological
and functional identity with 180 kDa membrane guanylate cyclase and ATP
signaling site. FEBS Lett. 296, 254–258. doi: 10.1016/0014-5793(92)80298-u
Marala, R. B., and Sharma, R. K. (1988). Characterization of atrial-natriuretic-
factor-receptor-coupled membrane guanylate cyclase from rat and mouse
testes. Biochem. J. 251, 301–304. doi: 10.1042/bj2510301
Marala, R. B., Sitaramayya, A., and Sharma, R. K. (1991). Dual regulation of atrial
natriuretic factor-dependent guanylate cyclase activity by ATP. FEBS Lett. 281,
73–76. doi: 10.1016/0014-5793(91)80361-6
Margulis, A., Goraczniak, R. M., Duda, T., Sharma, R. K., and Sitaramayya, A.
(1993). Structural and biochemical identity of retinal rod outer segment
membrane guanylate cyclase. Biochem. Biophys. Res. Commun. 194, 855–861.
doi: 10.1006/bbrc.1993.1900
Margulis, A., Pozdnyakov, N., and Sitaramayya, A. (1996). Activation of bovine
photoreceptor guanylate cyclase by S100 proteins. Biochem. Biophys. Res.
Commun. 218, 243–247. doi: 10.1006/bbrc.1996.0343
McFerran, B. W., Weiss, J. L., and Burgoyne, R. D. (1999). Neuronal Ca2+
sensor 1. Characterization of the myristoylated protein, its cellular effects
in permeabilized adrenal chromaffin cells, Ca2+-independent membrane
association and interaction with binding proteins, suggesting a role in rapid
Ca2+ signal transduction. J. Biol. Chem. 274, 30258–30265. doi: 10.1074/jbc.
274.42.30258
Meloche, S., McNicoll, N., Liu, B., Ong, H., and De Léan, A. (1988). Atrial
natriuretic factor R1 receptor from bovine adrenal zona glomerulosa:
purification, characterization and modulation by amiloride. Biochemistry 27,
8151–8158. doi: 10.1021/bi00421a025
Mendez, A., Burns, M. E., Sokal, I., Dizhoor, A. M., Baehr, W., Palczewski, K.,
et al. (2001). Role of guanylate cyclase-activating proteins (GCAPs) in setting
the flash sensitivity of rod photoreceptors. Proc. Natl. Acad. Sci. U S A 98,
9948–9953. doi: 10.1073/pnas.171308998
Meyer, M. R., Angele, A., Kremmer, E., Kaupp, U. B., and Muller, F. (2000).
A cGMP-signaling pathway in a subset of olfactory sensory neurons. Proc. Natl.
Acad. Sci. U S A 97, 10595–10600. doi: 10.1073/pnas.97.19.10595
Middendorff, R., Davidoff, M. S., Behrends, S., Mewe, M., Miethens, A., and
Müller, D. (2000). Multiple roles of the messenger molecule cGMP in testicular
function. Andrologia 32, 55–59.
Middendorff, R., Maronde, E., Paust, H. J., Müller, D., Davidoff, M., and
Olcese, J. (1996). Expression of C-type natriuretic peptide in the bovine
pineal gland. J. Neurochem. 67, 517–524. doi: 10.1046/j.1471-4159.1996.670
20517.x
Middendorff, R., Müller, D., Wichers, S., Holstein, A. F., and Davidoff, M. S.
(1997). Evidence for production and functional activity of nitric oxide in
seminiferous tubules and blood vessels of the human testis. J. Clin. Endocrinol.
Metab. 82, 4154–4161. doi: 10.1210/jc.82.12.4154
Frontiers in Molecular Neuroscience | www.frontiersin.org 21 September 2016 | Volume 9 | Article 83
Sharma et al. Membrane Guanylate Cyclase Networks
Mourdjeva, M., Russinova, A., Kyurkchiev, S., and Kehayov, I. (2001). Spatial and
temporal distribution of atrial natriuretic factor in the rat testis. Biol. Cell 93,
301–307. doi: 10.1016/s0248-4900(01)01119-4
Murad, F., Arnold, W. P., Mittal, C. K., and Braughler, J. M. (1979). Properties and
regulation of guanylate cyclase and some proposed functions for cyclic GMP.
Adv. Cyclic Nucleotide Res. 11, 175–204.
Nakano, A., Terasawa, M., Watanabe, M., Okazaki, K., Inoue, S., Kato, M., et al.
(1993). Distinct regional localization of neurocalcin, a Ca2+-binding protein,
in the bovine adrenal gland. J. Endocrinol. 138, 283–290. doi: 10.1677/joe.0.
1380283
Nambi, P., Aiyar, N. V., Roberts, A. N., and Sharma, R. K. (1982a). Relationship
of calcium and membrane guanylate cyclase in adrenocorticotropin-
induced steroidogenesis. Endocrinology 111, 196–200. doi: 10.1210/endo-
111-1-196
Nambi, P., Aiyar, N. V., and Sharma, R. K. (1982b). Adrenocorticotropin-
dependent particulate guanylate cyclase in rat adrenal and adrenocortical
carcinoma: comparison of its properties with soluble guanylate cyclase and its
relationship with ACTH-induced steroidogenesis.Arch. Biochem. Biophys. 217,
638–646. doi: 10.1016/0003-9861(82)90545-8
Nambi, P., and Sharma, R. K. (1981a). Adrenocorticotropic hormone-responsive
guanylate cyclase in the particulate fraction of rat adrenal glands. Endocrinology
108, 2025–2027. doi: 10.1210/endo-108-5-2025
Nambi, P., and Sharma, R. K. (1981b). Demonstration of ACTH-sensitive
particulate guanylate cyclase in adrenocortical carcinoma. Biochem. Biophys.
Res. Commun. 100, 508–514. doi: 10.1016/s0006-291x(81)80206-9
Nef, S., Fiumelli, H., de Castro, E., Raes, M. B., and Nef, P. (1995). Identification
of neuronal calcium sensor (NCS-1) possibly involved in the regulation of
receptor phosphorylation. J. Recept. Signal Transduct. Res. 15, 365–378. doi: 10.
3109/10799899509045227
Ogawa, H., Qiu, Y., Huang, L., Tam-Chang, S. W., Young, H. S., and Misono, K. S.
(2009). Structure of the atrial natriuretic peptide receptor extracellular
domain in the unbound and hormone-bound states by single-particle electron
microscopy. FEBS J. 276, 1347–1355. doi: 10.1111/j.1742-4658.2009.06870.x
Ogawa, H., Qiu, Y., Ogata, C. M., and Misono, K. S. (2004). Crystal structure
of hormone-bound atrial natriuretic peptide receptor extracellular domain:
rotationmechanism for transmembrane signal transduction. J. Biol. Chem. 279,
28625–28631. doi: 10.1074/jbc.m313222200
Okazaki, K., Watanabe, M., Ando, Y., Hagiwara, M., Terasawa, M., and
Hidaka, H. (1992). Full sequence of neurocalcin, a novel calcium-binding
protein abundant in central nervous system. Biochem. Biophys. Res. Commun.
185, 147–153. doi: 10.1016/s0006-291x(05)80968-4
Olafsson, P., Soares, H. D., Herzog, K. H., Wang, T., Morgan, J. I., and Lu, B.
(1997). The Ca2+ binding protein, frequenin is a nervous system-specific
protein in mouse preferentially localized in neurites. Brain Res. Mol. Brain Res.
44, 73–82. doi: 10.1016/s0169-328x(96)00188-x
Olafsson, P., Wang, T., and Lu, B. (1995). Molecular cloning and functional
characterization of the Xenopus Ca2+-binding protein frequenin. Proc. Natl.
Acad. Sci. U S A 92, 8001–8005. doi: 10.1073/pnas.92.17.8001
Olcese, J., Müller, D., Münker, M., and Schmidt, C. (1994). Natriuretic
peptides elevate cyclic 3′,5′-guanosine monophosphate levels in cultured rat
pinealocytes: evidence for guanylate cyclase-linked membrane receptors. Mol.
Cell. Endocrinol. 103, 95–100. doi: 10.1016/0303-7207(94)90074-4
Palczewski, K., Subbaraya, I., Gorczyca, W. A., Helekar, B. S., Ruiz, C. C.,
Ohguro, H., et al. (1994). Molecular cloning and characterization of retinal
photoreceptor guanylyl cyclase-activating protein.Neuron 13, 395–404. doi: 10.
1016/0896-6273(94)90355-7
Pandey, K. N., Oliver, P. M., Maeda, N., and Smithies, O. (1999). Hypertension
associated with decreased testosterone levels in natriuretic peptide receptor-A
gene-knockout and gene-duplicated mutant mouse models. Endocrinology 140,
5112–5119. doi: 10.1210/en.140.11.5112
Pandey, K. N., and Singh, S. (1990). Molecular cloning and expression of murine
guanylate cyclase/atrial natriuretic factor receptor cDNA. J. Biol. Chem. 265,
12342–12348.
Parat, M., Blanchet, J., and De Léan, A. (2010). Role of juxtamembrane and
transmembrane domains in the mechanism of natriuretic peptide receptor A
activation. Biochemistry 49, 4601–4610. doi: 10.1021/bi901711w
Paul, A. K. (1986). Particulate Guanylate Cyclase from Adrenocortical Carcinoma
494. Purification, Biochemical and Immunological Characterization.
[Dissertation].Memphis, TN: University of Tennessee
Paul, A. K., Marala, R. B., Jaiswal, R. K., and Sharma, R. K. (1987). Coexistence
of guanylate cyclase and atrial natriuretic factor receptor in a 180-kD protein.
Science 235, 1224–1226. doi: 10.1126/science.2881352
Perchellet, J. P., Shanker, G., and Sharma, R. (1978). Regulatory role of
guanosine 3′,5′-monophosphate in adrenocorticotropin hormone-induced
steroidogenesis. Science 199, 311–312. doi: 10.1126/science.202028
Perchellet, J. P., and Sharma, R. K. (1979). Mediatory role of calcium
and guanosine 3′,5′-monophosphate in adrenocorticotropin-induced
steroidogenesis by adrenal cells. Science 203, 1259–1261. doi: 10.1126/science.
34216
Perchellet, J. P., and Sharma, R. K. (1980). Ectopic α-adrenergic mediated
accumulation of guanosine 3′,5′-monophosphate in isolated adrenocortical
carcinoma cells. Endocrinology 106, 1589–1593. doi: 10.1210/endo-106-5-1589
Perrault, I., Rozet, J. M., Calvas, P., Gerber, S., Camuzat, A., Dollfus, H., et al.
(1996). Retinal-specific guanylate cyclase gene mutations in Leber’s congenital
amaurosis. Nat. Genet. 14, 461–464. doi: 10.1038/ng1296-461
Perrault, I., Rozet, J. M., Gerber, S., Ghazi, I., Leowski, C., Ducroq, D., et al.
(1999). Leber congenital amaurosis. Mol. Genet. Metab. 68, 200–208. doi: 10.
1006/mgme.1999.2906
Pertzev, A., Duda, T., and Sharma, R. K. (2010). Ca2+ sensor GCAP1: a
constitutive element of the ONE-GC-modulated odorant signal transduction
pathway. Biochemistry 49, 7303–7313. doi: 10.1021/bi101001v
Pongs, O., Lindemeier, J., Zhu, X. R., Theil, T., Engelkamp, D., Krah-Jentgens, I.,
et al. (1993). Frequenin–a novel calcium-binding protein that modulates
synaptic efficacy in the Drosophila nervous system. Neuron 1, 15–28. doi: 10.
1016/0896-6273(93)90267-u
Potter, L. R., and Garbers, D. L. (1992). Dephosphorylation of the guanylyl cyclase-
A receptor causes desensitization. J. Biol. Chem. 267, 14531–14534.
Potter, L. R., and Hunter, T. (1998). Identification and characterization of the
major phosphorylation sites of the B-type natriuretic peptide receptor. J. Biol.
Chem. 273, 15533–15539. doi: 10.1074/jbc.273.25.15533
Pozdnyakov, N., Goraczniak, R., Margulis, A., Duda, T., Sharma, R. K.,
Yoshida, A., et al. (1997). Structural and functional characterization of retinal
calcium-dependent guanylate cyclase activator protein (CD-GCAP): identity
with S100β protein. Biochemistry 36, 14159–14166. doi: 10.1021/bi971792l
Pozdnyakov, N., Yoshida, A., Cooper, N. G., Margulis, A., Duda, T., Sharma, R. K.,
et al. (1995). A novel calcium-dependent activator of retinal rod outer
segment membrane guanylate cyclase. Biochemistry 34, 14279–14283. doi: 10.
1021/bi00044a002
Pugh, E. N. Jr., and Cobbs, W. H. (1986). Visual transduction in vertebrate rods
and cones: a tale of two transmitters, calcium and cyclic GMP. Vision Res. 26,
1613–1643. doi: 10.1016/0042-6989(86)90051-9
Pugh, E. N. Jr., Duda, T., Sitaramayya, A., and Sharma, R. K. (1997).
Photoreceptor guanylate cyclases: a review. Biosci. Rep. 17, 429–473. doi: 10.
1023/A:1027365520442
Rambotti, M. G., Giambanco, I., Spreca, A., and Donato, R. (1999). S100B and
S100A1 proteins in bovine retina:their calcium-dependent stimulation
of a membrane-bound guanylate cyclase activity as investigated by
ultracytochemistry. Neuroscience 92, 1089–1101. doi: 10.1016/s0306-
4522(99)00074-3
Rondeau, J. J., McNicoll, N., Gagnon, J., Bouchard, N., Ong, H., and De
Lean, A. (1995). Stoichiometry of the atrial natriuretic factor-R1 receptor
complex in the bovine zona glomerulosa. Biochemistry 34, 2130–2136. doi: 10.
1021/bi00007a005
Rozet, J. M., Perrault, I., Gerber, S., Hanein, S., Barbet, F., Ducroq, D., et al.
(2001). Complete abolition of the retinal-specific guanylyl cyclase (retGC-1)
catalytic ability consistently leads to leber congenital amaurosis (LCA). Invest.
Ophthalmol. Vis. Sci. 42, 1190–1192.
Sayers, G., Beall, R. J., and Seelig, S. (1972). Isolated adrenal cells:
adrenocorticotropic hormone, calcium, steroidogenesis and cyclic adenosine
monophosphate. Science 175, 1131–1133. doi: 10.1126/science.175.
4026.1131
Schulz, S., Singh, S., Bellet, R. A., Singh, G., Tubb, D. J., Chin, H., et al.
(1989). The primary structure of a plasma membrane guanylate cyclase
demonstrates diversity within this new receptor family. Cell 58, 1155–1162.
doi: 10.1016/0092-8674(89)90513-8
Schulz, S., Wedel, B. J., Matthews, A., and Garbers, D. L. (1998). The cloning
and expression of a new guanylyl cyclase orphan receptor. J. Biol. Chem. 273,
1032–1037. doi: 10.1074/jbc.273.2.1032
Frontiers in Molecular Neuroscience | www.frontiersin.org 22 September 2016 | Volume 9 | Article 83
Sharma et al. Membrane Guanylate Cyclase Networks
Shanker, G., and Sharma, R. K. (1980). Characterization of ectopic α-adrenergic
binding receptors of adrenocortical carcinoma cells. Endocrinology 106,
1594–1598. doi: 10.1210/endo-106-5-1594
Sharma, R. K. (1972). Studies on adrenocortical carcinoma of rat cyclic nucleotide
phosphodiesterase activities. Cancer Res. 32, 1734–1736.
Sharma, R. K. (1973). Metabolic regulation of steroidogenesis in adrenocortical
carcinoma cells of rat. Effect of adrenocorticotropin and adenosine cyclic
3′:5′-monophosphate on corticosteroidogenesis. Eur. J. Biochem. 32, 506–512.
doi: 10.1111/j.1432-1033.1973.tb02635.x
Sharma, R. K. (1978). ‘‘Abnormal adrenocorticotropic hormone control in
adrenocortical carcinoma,’’ in Endocrine Control in Neoplasia, eds. R. K.
Sharma and W. E. Criss (New York, NY: Raven Press), 13–52.
Sharma, R. K. (1985). ‘‘Biochemical control in adrenocortical carcinoma,’’ in
Hormonally Responsive Tumors, ed. V. P. Hollander (New York, NY: Academic
Press), 185–217.
Sharma, R. K. (1988). Guanylate cyclase and the atrial natriuretic factor receptor.
Reply. Science 240, 805–806. doi: 10.1126/science.240.4853.805-a
Sharma, R. K. (2002). Evolution of the membrane guanylate cyclase transduction
system.Mol. Cell. Biochem. 230, 3–30. doi: 10.1007/978-1-4615-0927-1_1
Sharma, R. K. (2010). Membrane guanylate cyclase is a beautiful signal
transduction machine: overview. Mol. Cell. Biochem. 334, 3–36. doi: 10.
1007/s11010-009-0336-6
Sharma, R. K., Ahmed, N. K., and Shanker, G. (1976). Metabolic regulation
of steroidogenesis in isolated adrenal cells of rat. Relationship of
adrenocorticotropin-, adenosine 3′:5′-monophosphate-and guanosine
3′:5′-monophosphate-stimulated steroidogenesis with the activation of
protein kinase. Eur. J. Biochem. 70, 427–433. doi: 10.1111/j.1432-1033.1976.
tb11033.x
Sharma, R. K., Ahmed, N. K., Sutliff, L. S., and Brush, J. S. (1974). Metabolic
regulation of steroidogenesis in isolated adrenal cells of the rat. ACTH
regulation of cGMP and cAMP levels and steroidogenesis. FEBS Lett. 45,
107–110. doi: 10.1016/0014-5793(74)80822-7
Sharma, R. K., Baehr, W., Makino, C. L., and Duda, T. (2015). Ca2+ and
Ca2+-interlocked membrane guanylate cyclase signal modulation of neuronal
and cardiovascular signal transduction. Front. Mol. Neurosci. 8:7. doi: 10.
3389/fnmol.2015.00007
Sharma, R. K., and Duda, T. (1997). Plasma membrane guanylate cyclase. A
multimodule transduction system. Adv. Exp. Med. Biol. 407, 271–279. doi: 10.
1007/978-1-4899-1813-0_41
Sharma, R. K., and Duda, T. (2010). Odorant-linked ROS-GC subfamily
membrane guanylate cyclase transduction system. Mol. Cell. Biochem. 334,
181–189. doi: 10.1007/s11010-009-0333-9
Sharma, R. K., and Duda, T. (2012). Ca2+-sensors and ROS-GC: interlocked
sensory transduction elements: a review. Front. Mol. Neurosci. 5:42. doi: 10.
3389/fnmol.2012.00042
Sharma, R. K., and Duda, T. (2014a). Membrane guanylate cyclase, a multimodal
transduction machine: history, present and future directions. Front. Mol.
Neurosci. 7:56. doi: 10.3389/fnmol.2014.00056
Sharma, R. K., and Duda, T. (2014b). ‘‘Atrial natriuretic factor receptor guanylate
cyclase. The journey,’’ in Natriuretic Peptides. Physiology, Molecular Biology
and Clinical Applications, ed. K. N. Pandey (New York, NY: Nova Science
Publishers), 109–118.
Sharma, R. K., Duda, T., and Marala, R. B. (1989a). ‘‘A novel model depicting
the protein kinase C regulation of Atrial Natriuretic Factor-dependent 180-
kDa membrane guanylate cyclase,’’ in Advances in Atrial Peptide Research,
American Society of Hypertension, Symposium Series, (Vol. 3), eds. B. M.
Brenner and J. H. Laragh (New York, NY: Raven Press), 43–52.
Sharma, R. K., Marala, R. B., and Duda, T. M. (1989b). Purification and
characterization of the 180-kDa membrane guanylate cyclase containing
atrial natriuretic factor receptor from rat adrenal gland its regulation
by protein kinase C. Steroids 53, 437–460. doi: 10.1016/0039-128x(89)
90024-x
Sharma, R. K., Duda, T., Venkataraman, V., and Koch, K.-W. (2004). Calcium-
modulated mammalian membrane guanylate cyclase ROS-GC transduction
machinery in sensory neurons: a universal concept. Curr. Topics Biochem. Res.
6, 111–144.
Sharma, R. K., Jaiswal, R. K., and Duda, T. (1988a). ‘‘Second messenger role of
cyclic GMP in atrial natriuretic factor receptor mediated signal transduction:
180-kDa membrane guanylate cyclase, its coupling with atrial natriuretic factor
receptor and its regulation by protein kinase C,’’ in Biological and Molecular
Aspects of Atrial Factors. UCLA Symposia on Molecular and Cellular Biology,
New Series, (Vol. 81), ed. P. Needleman (New York, NY: Alan R. Liss, Inc.),
77–96.
Sharma, R. K., Marala, R. B., and Paul, A. K. (1988b). ‘‘Mediatory role of cyclic
GMP in receptor mediated signal transduction: membrane guanylate cyclase
and its coupling with atrial natriuretic factor receptor,’’ in Advances in Atrial
Peptide Research, American Society of Hypertension, Symposium series (Vol.
2), eds. B. M. Brenner and J. H. Laragh (New York, NY: Raven Press),
61–77.
Sharma, R. K., Makino, C. L., Hicks, D., and Duda, T. (2014). ROS-GC interlocked
Ca2+-sensor S100B protein signaling in cone photoreceptors: review. Front.
Mol. Neurosci. 7:21. doi: 10.3389/fnmol.2014.00021
Sharma, R. K., and Sawhney, R. S. (1978). Metabolic regulation of steroidogenesis
in isolated adrenal cell. Investigation of the adrenocorticotropic
hormone, guanosine 3′,5′-monophosphate and adenosine 3′,5′-
monophosphate control step. Biochemistry 17, 316–321. doi: 10.1021/bi0059
5a019
Sharma, R. K., Yadav, P., and Duda, T. (2001). Allosteric regulatory step and
configuration of the ATP-binding pocket in atrial natriuretic factor receptor
guanylate cyclase transduction mechanism. Can. J. Physiol. Pharmacol. 79,
682–691. doi: 10.1139/y01-033
Shi, S. J., Nguyen, H. T., Sharma, G. D., Navar, L. G., and Pandey, K. N.
(2001). Genetic disruption of atrial natriuretic peptide receptor-A alters
renin and angiotensin II levels. Am. J. Physiol. Renal Physiol. 281,
F665–F673.
Shyjan, A. W., de Sauvage, F. J., Gillett, N. A., Goeddel, D. V., and Lowe, D. G.
(1992). Molecular cloning of a retina-specific membrane guanylyl cyclase.
Neuron 9, 727–737. doi: 10.1016/0896-6273(92)90035-c
Singh, S., Lowe, D. G., Thorpe, D. S., Rodriguez, H., Kuang, W. J., Dangott, L. J.,
et al. (1988). Membrane guanylate cyclase is a cell-surface receptor
with homology to protein kinases. Nature 334, 708–712. doi: 10.1038/33
4708a0
Stryer, L. (1986). Cyclic GMP cascade of vision. Annu. Rev. Neurosci. 9, 87–119.
doi: 10.1146/annurev.neuro.9.1.87
Subbaraya, I., Ruiz, C. C., Helekar, B. S., Zhao, X., Gorczyca,W. A., Pettenati, M. J.,
et al. (1994). Molecular characterization of human and mouse photoreceptor
guanylate cyclase-activating protein (GCAP) and chromosomal localization of
the human gene. J. Biol. Chem. 269, 31080–31089.
Sun, L., Wang, H., Hu, J., Han, J., Matsunami, H., and Luo, M. (2009).
Guanylyl cyclase-D in the olfactory CO2 neurons is activated by bicarbonate.
Proc. Natl. Acad. Sci. U S A 106, 2041–2046. doi: 10.1073/pnas.08122
20106
Takayanagi, R., Snajdar, R. M., Imada, T., Tamura, M., Pandey, K. N.,
Misono, K. S., et al. (1987). Purification and characterization of two types
of atrial natriuretic factor receptors from bovine adrenal cortex: guanylate
cyclase-linked and cyclase-free receptors. Biochem. Biophys. Res. Commun. 144,
244–250. doi: 10.1016/s0006-291x(87)80502-8
Takeishi, A., Yu, Y. V., Hapiak, V. M., Bell, H. W., O’Leary, T., and Sengupta, P.
(2016). Receptor-type guanylyl cyclases confer thermosensory responses in. C.
elegans. Neuron 90, 235–244. doi: 10.1016/j.neuron.2016.03.002
Terasawa, M., Nakano, A., Kobayashi, R., and Hidaka, H. (1992). Neurocalcin:
a novel calcium-binding protein from bovine brain. J. Biol. Chem. 267,
19596–19599.
van den Akker, F., Zhang, X., Miyagi, M., Huo, X., Misono, K. S., and
Yee, V. C. (2000). Structure of the dimerized hormone-binding domain of
a guanylyl-cyclase-coupled receptor. Nature 406, 101–104. doi: 10.1038/350
17602
Venkataraman, V., Duda, T., Ravichandran, S., and Sharma, R. K. (2008).
Neurocalcin delta modulation of ROS-GC1, a new model of Ca2+ signaling.
Biochemistry 47, 6590–6601. doi: 10.1021/bi800394s
Venkataraman, V., Duda, T., and Sharma, R. K. (1998). The alpha(2D/A)-
adrenergic receptor-linked membrane guanylate cyclase: a new signal
transduction system in the pineal gland. FEBS Lett. 427, 69–73. doi: 10.
1016/s0014-5793(98)00396-2
Venkataraman, V., Duda, T., Vardi, N., Koch, K. W., and Sharma, R. K.
(2003). Calcium-modulated guanylate cyclase transduction machinery in the
photoreceptor–bipolar synaptic region. Biochemistry 42, 5640–5648. doi: 10.
1021/bi034025x
Frontiers in Molecular Neuroscience | www.frontiersin.org 23 September 2016 | Volume 9 | Article 83
Sharma et al. Membrane Guanylate Cyclase Networks
Venkataraman, V., Nagele, R., Duda, T., and Sharma, R. K. (2000). Rod outer
segment membrane guanylate cyclase type 1-linked stimulatory and inhibitory
calcium signaling systems in the pineal gland: biochemical, molecular
and immunohistochemical evidence. Biochemistry 39, 6042–6052. doi: 10.
1021/bi9929960
Vijay-Kumar, S., and Kumar, V. D. (1999). Crystal structure of recombinant
bovine neurocalcin. Nat. Struct. Biol. 6, 80–88. doi: 10.10.1038/4956
Wen, X. H., Dizhoor, A. M., andMakino, C. L. (2014). Membrane guanylyl cyclase
complexes shape the photoresponses of retinal rods and cones. Front. Mol.
Neurosci. 7:45. doi: 10.3389/fnmol.2014.00045
Wen, X. H., Duda, T., Pertzev, A., Venkataraman, V., Makino, C. L., and
Sharma, R. K. (2012). S100B serves as a Ca2+ sensor for ROS-GC1 guanylate
cyclase in cones but not in rods of the murine retina. Cell. Physiol. Biochem. 29,
417–430. doi: 10.1159/000338496
Woodruff, M. L., Sampath, A. P., Matthews, H. R., Krasnoperova, N. V., Lem, J.,
and Fain, G. L. (2002). Measurement of cytoplasmic calcium concentration in
the rods of wild-type and transducin knock-out mice. J. Physiol. 542, 843–854.
doi: 10.1113/jphysiol.2001.013987
Xu, J., Morris, L., Thapa, A., Ma, H., Michalakis, S., Biel, M., et al. (2013). cGMP
accumulation causes photoreceptor degeneration in CNG channel deficiency:
evidence of cGMP cytotoxicity independently of enhanced CNG channel
function. J. Neurosci. 33, 14939–14948. doi: 10.1523/JNEUROSCI.0909-13.
2013
Yang, R. B., Au, H. K., Tzeng, C. R., Tsai, M. T., Wu, P., Wu, Y. C., et al. (2010).
Characterization of a novel cell-surface protein expressed on human sperm.
Hum. Reprod. 25, 42–51. doi: 10.1093/humrep/dep359
Yang, R. B., and Garbers, D. L. (1997). Two eye guanylyl cyclases are expressed in
the same photoreceptor cells and form homomers in preference to heteromers.
J. Biol. Chem. 272, 13738–13742. doi: 10.1074/jbc.272.21.13738
Young, J. M., Waters, H., Dong, C., Fülle, H. J., and Liman, E. R. (2007).
Degeneration of the olfactory guanylyl cyclase D gene during primate
evolution. PLoS One 2:e884. doi: 10.1371/journal.pone.0000884
Zägel, P., Dell’Orco, D., and Koch, K. -W. (2013). The dimerization domain in
outer segment guanylate cyclase is a Ca2+-sensitive control switch module.
Biochemistry 52, 5065–5074. doi: 10.1021/bi400288p
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Sharma, Duda and Makino. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution and reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Molecular Neuroscience | www.frontiersin.org 24 September 2016 | Volume 9 | Article 83
